{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Analysis of how technology has revolunized clinical trials"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# BUSINESS UNDERSTANDING"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Data Understanding"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "#importing libraries\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import pycountry"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>PROACT</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2005-01|G050208</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2006-02-14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>A4070417|2U54MD007600-31</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-04-30</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2018-02-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03176225</td>\n",
       "      <td>Evaluate Safety and Effectiveness of XenoSure ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03176225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The purpose of this clinical trial is to colle...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Diseases</td>\n",
       "      <td>PROCEDURE: Open heart surgery to address the h...</td>\n",
       "      <td>Leakage rate at 6 month post-procedure measure...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>P15077-1</td>\n",
       "      <td>2017-08-15</td>\n",
       "      <td>2025-11-15</td>\n",
       "      <td>2026-02-15</td>\n",
       "      <td>2017-06-05</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-03-10</td>\n",
       "      <td>Chinese PLA General Hospital, Beijing, Beijing...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00199225</td>\n",
       "      <td>Evaluation of Possible Effects on the QT/ QTc ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00199225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This phase I trial will evaluate the effects o...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Human Experimentation (Human Volunteers)</td>\n",
       "      <td>DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...</td>\n",
       "      <td>To assess whether administration of a repeated...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>IC012RUP/1/04</td>\n",
       "      <td>2005-02</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2005-07</td>\n",
       "      <td>2005-09-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2005-12-15</td>\n",
       "      <td>Centre de Investigació de Medicaments-Intitut ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT05724225</td>\n",
       "      <td>\"Atriogenic Tricuspid Selected, Omics Profile,...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05724225</td>\n",
       "      <td>ATOMIC</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The aim of our study is to investigate the mol...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Tricuspid Valve Insufficiency</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Protein expression, Evaluation of the protein ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>4424</td>\n",
       "      <td>2021-10-06</td>\n",
       "      <td>2022-11-07</td>\n",
       "      <td>2023-12-29</td>\n",
       "      <td>2023-02-13</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-02-15</td>\n",
       "      <td>Istituto Auxologico Italiano IRCSS Ospedale Sa...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "2  NCT03176225  Evaluate Safety and Effectiveness of XenoSure ...   \n",
       "3  NCT00199225  Evaluation of Possible Effects on the QT/ QTc ...   \n",
       "4  NCT05724225  \"Atriogenic Tricuspid Selected, Omics Profile,...   \n",
       "\n",
       "                                      Study URL Acronym  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  PROACT   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325     NaN   \n",
       "2  https://clinicaltrials.gov/study/NCT03176225     NaN   \n",
       "3  https://clinicaltrials.gov/study/NCT00199225     NaN   \n",
       "4  https://clinicaltrials.gov/study/NCT05724225  ATOMIC   \n",
       "\n",
       "            Study Status                                      Brief Summary  \\\n",
       "0  ACTIVE_NOT_RECRUITING  Various patient groups with the On-X Valve can...   \n",
       "1  ACTIVE_NOT_RECRUITING  Clopidogrel is a prescription medicine used to...   \n",
       "2             RECRUITING  The purpose of this clinical trial is to colle...   \n",
       "3              COMPLETED  This phase I trial will evaluate the effects o...   \n",
       "4  ACTIVE_NOT_RECRUITING  The aim of our study is to investigate the mol...   \n",
       "\n",
       "  Study Results                                         Conditions  \\\n",
       "0            NO                                Heart Valve Disease   \n",
       "1            NO  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "2            NO                                     Heart Diseases   \n",
       "3            NO           Human Experimentation (Human Volunteers)   \n",
       "4            NO                      Tricuspid Valve Insufficiency   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "2  PROCEDURE: Open heart surgery to address the h...   \n",
       "3  DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...   \n",
       "4                                                NaN   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...  ...   \n",
       "1  Major adverse cardiovascular events (MACE) red...  ...   \n",
       "2  Leakage rate at 6 month post-procedure measure...  ...   \n",
       "3  To assess whether administration of a repeated...  ...   \n",
       "4  Protein expression, Evaluation of the protein ...  ...   \n",
       "\n",
       "                                        Study Design  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "4          Observational Model: |Time Perspective: p   \n",
       "\n",
       "                  Other IDs  Start Date Primary Completion Date  \\\n",
       "0           2005-01|G050208  2006-06-06              2022-12-31   \n",
       "1  A4070417|2U54MD007600-31  2020-09-01              2023-04-30   \n",
       "2                  P15077-1  2017-08-15              2025-11-15   \n",
       "3             IC012RUP/1/04     2005-02                     NaN   \n",
       "4                      4424  2021-10-06              2022-11-07   \n",
       "\n",
       "  Completion Date First Posted Results First Posted  Last Update Posted  \\\n",
       "0      2022-12-31   2006-02-14                  NaN          2022-09-14   \n",
       "1      2023-12-30   2018-02-01                  NaN          2023-05-30   \n",
       "2      2026-02-15   2017-06-05                  NaN          2023-03-10   \n",
       "3         2005-07   2005-09-20                  NaN          2005-12-15   \n",
       "4      2023-12-29   2023-02-13                  NaN          2023-02-15   \n",
       "\n",
       "                                           Locations Study Documents  \n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...             NaN  \n",
       "1  University Hospital at Carolina, Carolina, 009...             NaN  \n",
       "2  Chinese PLA General Hospital, Beijing, Beijing...             NaN  \n",
       "3  Centre de Investigació de Medicaments-Intitut ...             NaN  \n",
       "4  Istituto Auxologico Italiano IRCSS Ospedale Sa...             NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the heart dataset\n",
    "heart = pd.read_csv(\"Heart.csv\")\n",
    "heart.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02426125</td>\n",
       "      <td>A Study of Ramucirumab (LY3009806) Plus Doceta...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02426125</td>\n",
       "      <td>RANGE</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The main purpose of this study is to evaluate ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Urothelial Carcinoma</td>\n",
       "      <td>DRUG: Ramucirumab|DRUG: Docetaxel|DRUG: Placebo</td>\n",
       "      <td>Progression Free Survival (PFS), PFS defined a...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>15679|I4T-MC-JVDC|2014-003655-66</td>\n",
       "      <td>2015-07-13</td>\n",
       "      <td>2017-04-21</td>\n",
       "      <td>2022-07-26</td>\n",
       "      <td>2015-04-24</td>\n",
       "      <td>2019-01-25</td>\n",
       "      <td>2023-08-21</td>\n",
       "      <td>Highlands Oncology Group, Fayetteville, Arkans...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT04910425</td>\n",
       "      <td>PSMA-Targeted 18F-DCFPyL PET/MRI for the Detec...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04910425</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>This phase II trial studies how well 18F-DCFPy...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Prostate Carcinoma</td>\n",
       "      <td>DRUG: Fluorine F 18 DCFPyL|DRUG: Gadobenate Di...</td>\n",
       "      <td>18-F-DCFPyL positron emission tomography (PET)...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>NU 19U05|NCI-2021-05593|STU00212326|NU 19U05|P...</td>\n",
       "      <td>2023-06-17</td>\n",
       "      <td>2026-06-17</td>\n",
       "      <td>2028-07</td>\n",
       "      <td>2021-06-02</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-08-03</td>\n",
       "      <td>Northwestern University, Chicago, Illinois, 60...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04116125</td>\n",
       "      <td>Omitting Biopsy of SEntinel Lymph Node With Ra...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04116125</td>\n",
       "      <td>OBSERB</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>The OBSERB study is a multi-center, non-blinde...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Neoplasm Female|Lymphatic Metastasis</td>\n",
       "      <td>PROCEDURE: Radiotherapy</td>\n",
       "      <td>Disease-free survival, Disease free survival i...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: SIN...</td>\n",
       "      <td>2019-09-023</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2023-06-30</td>\n",
       "      <td>2025-06-30</td>\n",
       "      <td>2019-10-04</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-10-04</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03566225</td>\n",
       "      <td>Pioglitazone Versus Metformin as First Treatme...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03566225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Participants with PCOS will be divided into tw...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pioglitazone</td>\n",
       "      <td>DRUG: Pioglitazone|DRUG: Metformin|DRUG: Clomi...</td>\n",
       "      <td>Clinical pregnancy rate, Pregnancy rate diagno...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: SIN...</td>\n",
       "      <td>AinShamaU</td>\n",
       "      <td>2018-01-30</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2021-03-30</td>\n",
       "      <td>2018-06-25</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-06-02</td>\n",
       "      <td>Ain Shams Univerisity, Cairo, Egypt</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01756625</td>\n",
       "      <td>PREMIUM, Observational Study</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01756625</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>PREMIUM is an observational pharmaco-epidemiol...</td>\n",
       "      <td>NO</td>\n",
       "      <td>First Line WT KRAS mCRC</td>\n",
       "      <td>NaN</td>\n",
       "      <td>To compare PFS rate at 1 year with PFS in clin...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>PREMIUM</td>\n",
       "      <td>2010-01</td>\n",
       "      <td>2012-03</td>\n",
       "      <td>2013-06</td>\n",
       "      <td>2012-12-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2012-12-27</td>\n",
       "      <td>Institut Sainte-Catherine, Avignon, Vaucluse, ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT02426125  A Study of Ramucirumab (LY3009806) Plus Doceta...   \n",
       "1  NCT04910425  PSMA-Targeted 18F-DCFPyL PET/MRI for the Detec...   \n",
       "2  NCT04116125  Omitting Biopsy of SEntinel Lymph Node With Ra...   \n",
       "3  NCT03566225  Pioglitazone Versus Metformin as First Treatme...   \n",
       "4  NCT01756625                       PREMIUM, Observational Study   \n",
       "\n",
       "                                      Study URL Acronym        Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT02426125   RANGE           COMPLETED   \n",
       "1  https://clinicaltrials.gov/study/NCT04910425     NaN  NOT_YET_RECRUITING   \n",
       "2  https://clinicaltrials.gov/study/NCT04116125  OBSERB  NOT_YET_RECRUITING   \n",
       "3  https://clinicaltrials.gov/study/NCT03566225     NaN           COMPLETED   \n",
       "4  https://clinicaltrials.gov/study/NCT01756625     NaN             UNKNOWN   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  The main purpose of this study is to evaluate ...           YES   \n",
       "1  This phase II trial studies how well 18F-DCFPy...            NO   \n",
       "2  The OBSERB study is a multi-center, non-blinde...            NO   \n",
       "3  Participants with PCOS will be divided into tw...            NO   \n",
       "4  PREMIUM is an observational pharmaco-epidemiol...            NO   \n",
       "\n",
       "                                    Conditions  \\\n",
       "0                         Urothelial Carcinoma   \n",
       "1                           Prostate Carcinoma   \n",
       "2  Breast Neoplasm Female|Lymphatic Metastasis   \n",
       "3                                 Pioglitazone   \n",
       "4                      First Line WT KRAS mCRC   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0    DRUG: Ramucirumab|DRUG: Docetaxel|DRUG: Placebo   \n",
       "1  DRUG: Fluorine F 18 DCFPyL|DRUG: Gadobenate Di...   \n",
       "2                            PROCEDURE: Radiotherapy   \n",
       "3  DRUG: Pioglitazone|DRUG: Metformin|DRUG: Clomi...   \n",
       "4                                                NaN   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  Progression Free Survival (PFS), PFS defined a...  ...   \n",
       "1  18-F-DCFPyL positron emission tomography (PET)...  ...   \n",
       "2  Disease-free survival, Disease free survival i...  ...   \n",
       "3  Clinical pregnancy rate, Pregnancy rate diagno...  ...   \n",
       "4  To compare PFS rate at 1 year with PFS in clin...  ...   \n",
       "\n",
       "                                        Study Design  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: SIN...   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: SIN...   \n",
       "4          Observational Model: |Time Perspective: p   \n",
       "\n",
       "                                           Other IDs  Start Date  \\\n",
       "0                   15679|I4T-MC-JVDC|2014-003655-66  2015-07-13   \n",
       "1  NU 19U05|NCI-2021-05593|STU00212326|NU 19U05|P...  2023-06-17   \n",
       "2                                        2019-09-023  2020-07-01   \n",
       "3                                          AinShamaU  2018-01-30   \n",
       "4                                            PREMIUM     2010-01   \n",
       "\n",
       "  Primary Completion Date Completion Date First Posted Results First Posted  \\\n",
       "0              2017-04-21      2022-07-26   2015-04-24           2019-01-25   \n",
       "1              2026-06-17         2028-07   2021-06-02                  NaN   \n",
       "2              2023-06-30      2025-06-30   2019-10-04                  NaN   \n",
       "3              2021-02-28      2021-03-30   2018-06-25                  NaN   \n",
       "4                 2012-03         2013-06   2012-12-27                  NaN   \n",
       "\n",
       "   Last Update Posted                                          Locations  \\\n",
       "0          2023-08-21  Highlands Oncology Group, Fayetteville, Arkans...   \n",
       "1          2022-08-03  Northwestern University, Chicago, Illinois, 60...   \n",
       "2          2019-10-04                                                NaN   \n",
       "3          2021-06-02                Ain Shams Univerisity, Cairo, Egypt   \n",
       "4          2012-12-27  Institut Sainte-Catherine, Avignon, Vaucluse, ...   \n",
       "\n",
       "                            Study Documents  \n",
       "0  Study Protocol|Statistical Analysis Plan  \n",
       "1                                       NaN  \n",
       "2                                       NaN  \n",
       "3                                       NaN  \n",
       "4                                       NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the cancer dataset\n",
    "can = pd.read_csv(\"Cancer-studies.csv\")\n",
    "can.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT04614025</td>\n",
       "      <td>Open-label Multicenter Study to Evaluate the E...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04614025</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This clinical trial will examine if a new trea...</td>\n",
       "      <td>NO</td>\n",
       "      <td>COVID|ARDS</td>\n",
       "      <td>BIOLOGICAL: PLX-PAD</td>\n",
       "      <td>Number of ventilator-free days, 28 days</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>PLX-COV-03</td>\n",
       "      <td>2020-10-19</td>\n",
       "      <td>2021-08-04</td>\n",
       "      <td>2023-01</td>\n",
       "      <td>2020-11-03</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-12-21</td>\n",
       "      <td>Charite Campus Virchow, Berlin, 10117, Germany...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT04646525</td>\n",
       "      <td>The Relationship Between Covid-19 Infection in...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04646525</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>We aimed to find out whether the tonsils and n...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Covid19|Immune Deficiency|Tonsillitis|Tonsil H...</td>\n",
       "      <td>DIAGNOSTIC_TEST: Physical examination</td>\n",
       "      <td>The primary outcome of our study was the evalu...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2020/480</td>\n",
       "      <td>2020-10-01</td>\n",
       "      <td>2021-02-01</td>\n",
       "      <td>2021-02-01</td>\n",
       "      <td>2020-11-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020-11-30</td>\n",
       "      <td>Selcuk University, Konya, Selcuklu, 42100, Turkey</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04333225</td>\n",
       "      <td>Hydroxychloroquine in the Prevention of COVID-...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04333225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>In order to assess the efficacy of hydroxychlo...</td>\n",
       "      <td>YES</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>DRUG: Hydroxychloroquine</td>\n",
       "      <td>Number of Participants Infected With COVID-19 ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>020-132</td>\n",
       "      <td>2020-04-03</td>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>2020-04-03</td>\n",
       "      <td>2021-08-02</td>\n",
       "      <td>2021-08-20</td>\n",
       "      <td>Baylor University Medical Center, Dallas, Texa...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT04996225</td>\n",
       "      <td>Effect of Aerobics and Balancing Exercises on ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04996225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The recently emerged coronavirus named Severe ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Corona Virus Infection</td>\n",
       "      <td>OTHER: Aerobics exercises, Balance exercises</td>\n",
       "      <td>SPSS for Windows, version 22 (SPSS Inc., Chica...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>A,B E COVID 19</td>\n",
       "      <td>2021-08-01</td>\n",
       "      <td>2022-10-25</td>\n",
       "      <td>2023-02-10</td>\n",
       "      <td>2021-08-09</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-02-22</td>\n",
       "      <td>Ahmed.Assem, Sohag, 82951, Egypt</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT04858425</td>\n",
       "      <td>Safety and Efficacy of Niclosamide in Patients...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04858425</td>\n",
       "      <td>RESERVOIR</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This is a 2-part, 2-arm, Phase 2 , multicentre...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Covid19</td>\n",
       "      <td>DRUG: Niclosamide|DRUG: Placebo</td>\n",
       "      <td>SAEs, Serious adverse event (SAE) coded by Sys...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>AZ-NICL-COV-1</td>\n",
       "      <td>2021-04-30</td>\n",
       "      <td>2022-06-04</td>\n",
       "      <td>2023-05</td>\n",
       "      <td>2021-04-26</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-04-06</td>\n",
       "      <td>Central Alabama Research, Birmingham, Alabama,...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT04614025  Open-label Multicenter Study to Evaluate the E...   \n",
       "1  NCT04646525  The Relationship Between Covid-19 Infection in...   \n",
       "2  NCT04333225  Hydroxychloroquine in the Prevention of COVID-...   \n",
       "3  NCT04996225  Effect of Aerobics and Balancing Exercises on ...   \n",
       "4  NCT04858425  Safety and Efficacy of Niclosamide in Patients...   \n",
       "\n",
       "                                      Study URL    Acronym  \\\n",
       "0  https://clinicaltrials.gov/study/NCT04614025        NaN   \n",
       "1  https://clinicaltrials.gov/study/NCT04646525        NaN   \n",
       "2  https://clinicaltrials.gov/study/NCT04333225        NaN   \n",
       "3  https://clinicaltrials.gov/study/NCT04996225        NaN   \n",
       "4  https://clinicaltrials.gov/study/NCT04858425  RESERVOIR   \n",
       "\n",
       "            Study Status                                      Brief Summary  \\\n",
       "0  ACTIVE_NOT_RECRUITING  This clinical trial will examine if a new trea...   \n",
       "1                UNKNOWN  We aimed to find out whether the tonsils and n...   \n",
       "2              COMPLETED  In order to assess the efficacy of hydroxychlo...   \n",
       "3              COMPLETED  The recently emerged coronavirus named Severe ...   \n",
       "4  ACTIVE_NOT_RECRUITING  This is a 2-part, 2-arm, Phase 2 , multicentre...   \n",
       "\n",
       "  Study Results                                         Conditions  \\\n",
       "0            NO                                         COVID|ARDS   \n",
       "1            NO  Covid19|Immune Deficiency|Tonsillitis|Tonsil H...   \n",
       "2           YES                                           COVID-19   \n",
       "3            NO                             Corona Virus Infection   \n",
       "4            NO                                            Covid19   \n",
       "\n",
       "                                  Interventions  \\\n",
       "0                           BIOLOGICAL: PLX-PAD   \n",
       "1         DIAGNOSTIC_TEST: Physical examination   \n",
       "2                      DRUG: Hydroxychloroquine   \n",
       "3  OTHER: Aerobics exercises, Balance exercises   \n",
       "4               DRUG: Niclosamide|DRUG: Placebo   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0            Number of ventilator-free days, 28 days  ...   \n",
       "1  The primary outcome of our study was the evalu...  ...   \n",
       "2  Number of Participants Infected With COVID-19 ...  ...   \n",
       "3  SPSS for Windows, version 22 (SPSS Inc., Chica...  ...   \n",
       "4  SAEs, Serious adverse event (SAE) coded by Sys...  ...   \n",
       "\n",
       "                                        Study Design       Other IDs  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...      PLX-COV-03   \n",
       "1          Observational Model: |Time Perspective: p        2020/480   \n",
       "2  Allocation: NON_RANDOMIZED|Intervention Model:...         020-132   \n",
       "3  Allocation: RANDOMIZED|Intervention Model: PAR...  A,B E COVID 19   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR...   AZ-NICL-COV-1   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0  2020-10-19              2021-08-04         2023-01   2020-11-03   \n",
       "1  2020-10-01              2021-02-01      2021-02-01   2020-11-30   \n",
       "2  2020-04-03              2020-06-30      2020-06-30   2020-04-03   \n",
       "3  2021-08-01              2022-10-25      2023-02-10   2021-08-09   \n",
       "4  2021-04-30              2022-06-04         2023-05   2021-04-26   \n",
       "\n",
       "  Results First Posted  Last Update Posted  \\\n",
       "0                  NaN          2022-12-21   \n",
       "1                  NaN          2020-11-30   \n",
       "2           2021-08-02          2021-08-20   \n",
       "3                  NaN          2023-02-22   \n",
       "4                  NaN          2023-04-06   \n",
       "\n",
       "                                           Locations  \\\n",
       "0  Charite Campus Virchow, Berlin, 10117, Germany...   \n",
       "1  Selcuk University, Konya, Selcuklu, 42100, Turkey   \n",
       "2  Baylor University Medical Center, Dallas, Texa...   \n",
       "3                   Ahmed.Assem, Sohag, 82951, Egypt   \n",
       "4  Central Alabama Research, Birmingham, Alabama,...   \n",
       "\n",
       "                            Study Documents  \n",
       "0                                       NaN  \n",
       "1                                       NaN  \n",
       "2  Study Protocol|Statistical Analysis Plan  \n",
       "3                                       NaN  \n",
       "4                                       NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the covid dataset\n",
    "cov = pd.read_csv(\"Covid 19-studies.csv\")\n",
    "cov.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00914225</td>\n",
       "      <td>Effect of Bednets and a Water Purification Dev...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00914225</td>\n",
       "      <td>ITN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>In many areas of the world most severely affec...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV Infections|Human Immunodeficiency Virus|Ma...</td>\n",
       "      <td>OTHER: Bednets and Water Purification</td>\n",
       "      <td>To determine the effect of LLIN and a simple m...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>35464-B|SSC#1554</td>\n",
       "      <td>2009-09</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2009-06-04</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015-05-29</td>\n",
       "      <td>Kisii Provincial Hospital, Kisii, Kenya|Kisumu...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02167425</td>\n",
       "      <td>Study of Integrating Antiretroviral Therapy Wi...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02167425</td>\n",
       "      <td>IMAT</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>To improve ART initiation among people who inj...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV|Opioid Dependence</td>\n",
       "      <td>OTHER: IMAT</td>\n",
       "      <td>Time to CD4 Screening, Number of days between ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>IMAT-01|R34DA037787</td>\n",
       "      <td>2015-02</td>\n",
       "      <td>2017-03</td>\n",
       "      <td>2017-03</td>\n",
       "      <td>2014-06-19</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015-11-23</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT01423825</td>\n",
       "      <td>Evaluating the Safety and Immune Response to a...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01423825</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is an extension of the HVTN 073/SAAVI 102...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>BIOLOGICAL: Sub C gp140 Vaccine|BIOLOGICAL: MF...</td>\n",
       "      <td>Safety data, including signs and symptoms of l...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>HVTN 073E/SAAVI 102|11824</td>\n",
       "      <td>2011-08</td>\n",
       "      <td>2013-07</td>\n",
       "      <td>2013-07</td>\n",
       "      <td>2011-08-26</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-14</td>\n",
       "      <td>Brigham and Women's Hospital Vaccine CRS (BWH ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT02098525</td>\n",
       "      <td>Clinical Outcomes of Cryptococcal Meningitis A...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02098525</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Cryptococcal meningitis is one of the most com...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cryptococcal Meningitis|HIV/AIDS</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Long-term survival rate of CM, To describe lon...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>HIVCM-01</td>\n",
       "      <td>2013-11</td>\n",
       "      <td>2013-12</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2014-03-28</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2014-03-28</td>\n",
       "      <td>Division of Infectious Diseases, Department of...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT04515225</td>\n",
       "      <td>COVID-19 Prevalence in HIV-infected Patients</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04515225</td>\n",
       "      <td>SeCoVIHA</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>North-east area of France was hit in February ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV Infections</td>\n",
       "      <td>OTHER: Blood Sample</td>\n",
       "      <td>Seroprevalence of SARS-CoV-2, SARS-CoV-2 antib...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>7947</td>\n",
       "      <td>2020-11-04</td>\n",
       "      <td>2022-05-03</td>\n",
       "      <td>2022-05-03</td>\n",
       "      <td>2020-08-17</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-08-10</td>\n",
       "      <td>Hôpitaux Universitaires de Strasbourg, Strasbo...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00914225  Effect of Bednets and a Water Purification Dev...   \n",
       "1  NCT02167425  Study of Integrating Antiretroviral Therapy Wi...   \n",
       "2  NCT01423825  Evaluating the Safety and Immune Response to a...   \n",
       "3  NCT02098525  Clinical Outcomes of Cryptococcal Meningitis A...   \n",
       "4  NCT04515225       COVID-19 Prevalence in HIV-infected Patients   \n",
       "\n",
       "                                      Study URL   Acronym Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00914225       ITN    COMPLETED   \n",
       "1  https://clinicaltrials.gov/study/NCT02167425      IMAT      UNKNOWN   \n",
       "2  https://clinicaltrials.gov/study/NCT01423825       NaN    COMPLETED   \n",
       "3  https://clinicaltrials.gov/study/NCT02098525       NaN    COMPLETED   \n",
       "4  https://clinicaltrials.gov/study/NCT04515225  SeCoVIHA      UNKNOWN   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  In many areas of the world most severely affec...            NO   \n",
       "1  To improve ART initiation among people who inj...            NO   \n",
       "2  This is an extension of the HVTN 073/SAAVI 102...            NO   \n",
       "3  Cryptococcal meningitis is one of the most com...            NO   \n",
       "4  North-east area of France was hit in February ...            NO   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  HIV Infections|Human Immunodeficiency Virus|Ma...   \n",
       "1                              HIV|Opioid Dependence   \n",
       "2                                     HIV Infections   \n",
       "3                   Cryptococcal Meningitis|HIV/AIDS   \n",
       "4                                     HIV Infections   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0              OTHER: Bednets and Water Purification   \n",
       "1                                        OTHER: IMAT   \n",
       "2  BIOLOGICAL: Sub C gp140 Vaccine|BIOLOGICAL: MF...   \n",
       "3                                                NaN   \n",
       "4                                OTHER: Blood Sample   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  To determine the effect of LLIN and a simple m...  ...   \n",
       "1  Time to CD4 Screening, Number of days between ...  ...   \n",
       "2  Safety data, including signs and symptoms of l...  ...   \n",
       "3  Long-term survival rate of CM, To describe lon...  ...   \n",
       "4  Seroprevalence of SARS-CoV-2, SARS-CoV-2 antib...  ...   \n",
       "\n",
       "                                        Study Design  \\\n",
       "0          Observational Model: |Time Perspective: p   \n",
       "1          Observational Model: |Time Perspective: p   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3          Observational Model: |Time Perspective: p   \n",
       "4          Observational Model: |Time Perspective: p   \n",
       "\n",
       "                   Other IDs  Start Date Primary Completion Date  \\\n",
       "0           35464-B|SSC#1554     2009-09                 2011-12   \n",
       "1        IMAT-01|R34DA037787     2015-02                 2017-03   \n",
       "2  HVTN 073E/SAAVI 102|11824     2011-08                 2013-07   \n",
       "3                   HIVCM-01     2013-11                 2013-12   \n",
       "4                       7947  2020-11-04              2022-05-03   \n",
       "\n",
       "  Completion Date First Posted Results First Posted  Last Update Posted  \\\n",
       "0         2011-12   2009-06-04                  NaN          2015-05-29   \n",
       "1         2017-03   2014-06-19                  NaN          2015-11-23   \n",
       "2         2013-07   2011-08-26                  NaN          2021-10-14   \n",
       "3             NaN   2014-03-28                  NaN          2014-03-28   \n",
       "4      2022-05-03   2020-08-17                  NaN          2021-08-10   \n",
       "\n",
       "                                           Locations Study Documents  \n",
       "0  Kisii Provincial Hospital, Kisii, Kenya|Kisumu...             NaN  \n",
       "1                                                NaN             NaN  \n",
       "2  Brigham and Women's Hospital Vaccine CRS (BWH ...             NaN  \n",
       "3  Division of Infectious Diseases, Department of...             NaN  \n",
       "4  Hôpitaux Universitaires de Strasbourg, Strasbo...             NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the HIV data set\n",
    "hiv = pd.read_csv(\"HIV-studies.csv\")\n",
    "hiv.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01976325</td>\n",
       "      <td>Evaluating the Ottawa Malaria Decision Aid</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01976325</td>\n",
       "      <td>OMDA</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>BRIEF SUMMARY\\n\\nCanadians often visit areas w...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>OTHER: Ottawa Malaria Decision Aid</td>\n",
       "      <td>Travellers' Knowledge Score, The traveller's k...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2010462-01H</td>\n",
       "      <td>2014-01</td>\n",
       "      <td>2015-11</td>\n",
       "      <td>2015-11</td>\n",
       "      <td>2013-11-05</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015-04-16</td>\n",
       "      <td>National Capital Region Occupational Health Cl...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00914225</td>\n",
       "      <td>Effect of Bednets and a Water Purification Dev...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00914225</td>\n",
       "      <td>ITN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>In many areas of the world most severely affec...</td>\n",
       "      <td>NO</td>\n",
       "      <td>HIV Infections|Human Immunodeficiency Virus|Ma...</td>\n",
       "      <td>OTHER: Bednets and Water Purification</td>\n",
       "      <td>To determine the effect of LLIN and a simple m...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>35464-B|SSC#1554</td>\n",
       "      <td>2009-09</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2009-06-04</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015-05-29</td>\n",
       "      <td>Kisii Provincial Hospital, Kisii, Kenya|Kisumu...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT05605925</td>\n",
       "      <td>Ivermectin-artemisinin Combination Therapy for...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05605925</td>\n",
       "      <td>IVIME</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>Malaria remains a leading cause of morbidity a...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>DRUG: Artemether/lumefantrine|DRUG: Ivermectin</td>\n",
       "      <td>Malaria transmission rates in a household, Mal...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>MAKSHSREC-2021-237</td>\n",
       "      <td>2022-08-04</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-11-04</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-11-04</td>\n",
       "      <td>ST. Paul's Health Center, Kasese, Uganda</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01464125</td>\n",
       "      <td>Fosmidomycin and Azithromycin for Acute Uncomp...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01464125</td>\n",
       "      <td>JP011</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>The aim of this study is to evaluate the role ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>DRUG: Fosmidomycin|DRUG: Azithromycin</td>\n",
       "      <td>day 28 cure rate of &gt;95%, Efficacy of fosmidom...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>JP011</td>\n",
       "      <td>2008-11</td>\n",
       "      <td>2009-10</td>\n",
       "      <td>2011-12</td>\n",
       "      <td>2011-11-03</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2011-11-03</td>\n",
       "      <td>Mahidol University, Bangkok, 10400, Thailand</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT02557425</td>\n",
       "      <td>Prophylaxis Against Malaria to Enhance Child D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02557425</td>\n",
       "      <td>PROTECT</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Each year, \\~85.3 million pregnant women are a...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Neurobehavioral Manifestations</td>\n",
       "      <td>OTHER: No intervention in PROTECT</td>\n",
       "      <td>Z-scores for Overall cognitive ability, 12 mon...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>1506994146</td>\n",
       "      <td>2015-10</td>\n",
       "      <td>2021-08-05</td>\n",
       "      <td>2021-08-05</td>\n",
       "      <td>2015-09-23</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-08-25</td>\n",
       "      <td>Tororo District Hospital, Tororo, Uganda</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT01976325         Evaluating the Ottawa Malaria Decision Aid   \n",
       "1  NCT00914225  Effect of Bednets and a Water Purification Dev...   \n",
       "2  NCT05605925  Ivermectin-artemisinin Combination Therapy for...   \n",
       "3  NCT01464125  Fosmidomycin and Azithromycin for Acute Uncomp...   \n",
       "4  NCT02557425  Prophylaxis Against Malaria to Enhance Child D...   \n",
       "\n",
       "                                      Study URL  Acronym Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT01976325     OMDA      UNKNOWN   \n",
       "1  https://clinicaltrials.gov/study/NCT00914225      ITN    COMPLETED   \n",
       "2  https://clinicaltrials.gov/study/NCT05605925    IVIME   RECRUITING   \n",
       "3  https://clinicaltrials.gov/study/NCT01464125    JP011      UNKNOWN   \n",
       "4  https://clinicaltrials.gov/study/NCT02557425  PROTECT    COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  BRIEF SUMMARY\\n\\nCanadians often visit areas w...            NO   \n",
       "1  In many areas of the world most severely affec...            NO   \n",
       "2  Malaria remains a leading cause of morbidity a...            NO   \n",
       "3  The aim of this study is to evaluate the role ...            NO   \n",
       "4  Each year, \\~85.3 million pregnant women are a...            NO   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                            Malaria   \n",
       "1  HIV Infections|Human Immunodeficiency Virus|Ma...   \n",
       "2                                            Malaria   \n",
       "3                                            Malaria   \n",
       "4                     Neurobehavioral Manifestations   \n",
       "\n",
       "                                    Interventions  \\\n",
       "0              OTHER: Ottawa Malaria Decision Aid   \n",
       "1           OTHER: Bednets and Water Purification   \n",
       "2  DRUG: Artemether/lumefantrine|DRUG: Ivermectin   \n",
       "3           DRUG: Fosmidomycin|DRUG: Azithromycin   \n",
       "4               OTHER: No intervention in PROTECT   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  Travellers' Knowledge Score, The traveller's k...  ...   \n",
       "1  To determine the effect of LLIN and a simple m...  ...   \n",
       "2  Malaria transmission rates in a household, Mal...  ...   \n",
       "3  day 28 cure rate of >95%, Efficacy of fosmidom...  ...   \n",
       "4  Z-scores for Overall cognitive ability, 12 mon...  ...   \n",
       "\n",
       "                                        Study Design           Other IDs  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...         2010462-01H   \n",
       "1          Observational Model: |Time Perspective: p    35464-B|SSC#1554   \n",
       "2  Allocation: RANDOMIZED|Intervention Model: PAR...  MAKSHSREC-2021-237   \n",
       "3  Allocation: NON_RANDOMIZED|Intervention Model:...               JP011   \n",
       "4          Observational Model: |Time Perspective: p          1506994146   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0     2014-01                 2015-11         2015-11   2013-11-05   \n",
       "1     2009-09                 2011-12         2011-12   2009-06-04   \n",
       "2  2022-08-04              2022-12-31      2022-12-31   2022-11-04   \n",
       "3     2008-11                 2009-10         2011-12   2011-11-03   \n",
       "4     2015-10              2021-08-05      2021-08-05   2015-09-23   \n",
       "\n",
       "  Results First Posted  Last Update Posted  \\\n",
       "0                  NaN          2015-04-16   \n",
       "1                  NaN          2015-05-29   \n",
       "2                  NaN          2022-11-04   \n",
       "3                  NaN          2011-11-03   \n",
       "4                  NaN          2021-08-25   \n",
       "\n",
       "                                           Locations Study Documents  \n",
       "0  National Capital Region Occupational Health Cl...             NaN  \n",
       "1  Kisii Provincial Hospital, Kisii, Kenya|Kisumu...             NaN  \n",
       "2           ST. Paul's Health Center, Kasese, Uganda             NaN  \n",
       "3       Mahidol University, Bangkok, 10400, Thailand             NaN  \n",
       "4           Tororo District Hospital, Tororo, Uganda             NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the malaria data set\n",
    "mal = pd.read_csv(\"malaria.csv\")\n",
    "mal.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02708225</td>\n",
       "      <td>The Influence of Medical Clowns on the Perform...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02708225</td>\n",
       "      <td>clowns</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Medical clowns are known to assist in relaxing...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Asthma|Pneumonia</td>\n",
       "      <td>BEHAVIORAL: medical clown</td>\n",
       "      <td>length of experium (seconds), length of experi...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>0026-15</td>\n",
       "      <td>2016-03</td>\n",
       "      <td>2016-10</td>\n",
       "      <td>2017-10</td>\n",
       "      <td>2016-03-15</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2016-03-15</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03962725</td>\n",
       "      <td>Avoiding Neuromuscular Blockers to Reduce Comp...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03962725</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The goal of this study to evaluate whether eli...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Respiratory Failure|Respiratory Infection|Aspi...</td>\n",
       "      <td>DRUG: Neuromuscular Blocking Agents|DRUG: Anes...</td>\n",
       "      <td>Number of participants who either had postoper...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2019P000260</td>\n",
       "      <td>2019-08-07</td>\n",
       "      <td>2022-12-19</td>\n",
       "      <td>2022-12-19</td>\n",
       "      <td>2019-05-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-02-02</td>\n",
       "      <td>Massachusetts General Hospital, Boston, Massac...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04646525</td>\n",
       "      <td>The Relationship Between Covid-19 Infection in...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04646525</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>We aimed to find out whether the tonsils and n...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Covid19|Immune Deficiency|Tonsillitis|Tonsil H...</td>\n",
       "      <td>DIAGNOSTIC_TEST: Physical examination</td>\n",
       "      <td>The primary outcome of our study was the evalu...</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational Model: |Time Perspective: p</td>\n",
       "      <td>2020/480</td>\n",
       "      <td>2020-10-01</td>\n",
       "      <td>2021-02-01</td>\n",
       "      <td>2021-02-01</td>\n",
       "      <td>2020-11-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020-11-30</td>\n",
       "      <td>Selcuk University, Konya, Selcuklu, 42100, Turkey</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT04333225</td>\n",
       "      <td>Hydroxychloroquine in the Prevention of COVID-...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04333225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>In order to assess the efficacy of hydroxychlo...</td>\n",
       "      <td>YES</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>DRUG: Hydroxychloroquine</td>\n",
       "      <td>Number of Participants Infected With COVID-19 ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>020-132</td>\n",
       "      <td>2020-04-03</td>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>2020-04-03</td>\n",
       "      <td>2021-08-02</td>\n",
       "      <td>2021-08-20</td>\n",
       "      <td>Baylor University Medical Center, Dallas, Texa...</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT04858425</td>\n",
       "      <td>Safety and Efficacy of Niclosamide in Patients...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04858425</td>\n",
       "      <td>RESERVOIR</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>This is a 2-part, 2-arm, Phase 2 , multicentre...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Covid19</td>\n",
       "      <td>DRUG: Niclosamide|DRUG: Placebo</td>\n",
       "      <td>SAEs, Serious adverse event (SAE) coded by Sys...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>AZ-NICL-COV-1</td>\n",
       "      <td>2021-04-30</td>\n",
       "      <td>2022-06-04</td>\n",
       "      <td>2023-05</td>\n",
       "      <td>2021-04-26</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-04-06</td>\n",
       "      <td>Central Alabama Research, Birmingham, Alabama,...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 30 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT02708225  The Influence of Medical Clowns on the Perform...   \n",
       "1  NCT03962725  Avoiding Neuromuscular Blockers to Reduce Comp...   \n",
       "2  NCT04646525  The Relationship Between Covid-19 Infection in...   \n",
       "3  NCT04333225  Hydroxychloroquine in the Prevention of COVID-...   \n",
       "4  NCT04858425  Safety and Efficacy of Niclosamide in Patients...   \n",
       "\n",
       "                                      Study URL    Acronym  \\\n",
       "0  https://clinicaltrials.gov/study/NCT02708225     clowns   \n",
       "1  https://clinicaltrials.gov/study/NCT03962725        NaN   \n",
       "2  https://clinicaltrials.gov/study/NCT04646525        NaN   \n",
       "3  https://clinicaltrials.gov/study/NCT04333225        NaN   \n",
       "4  https://clinicaltrials.gov/study/NCT04858425  RESERVOIR   \n",
       "\n",
       "            Study Status                                      Brief Summary  \\\n",
       "0                UNKNOWN  Medical clowns are known to assist in relaxing...   \n",
       "1             TERMINATED  The goal of this study to evaluate whether eli...   \n",
       "2                UNKNOWN  We aimed to find out whether the tonsils and n...   \n",
       "3              COMPLETED  In order to assess the efficacy of hydroxychlo...   \n",
       "4  ACTIVE_NOT_RECRUITING  This is a 2-part, 2-arm, Phase 2 , multicentre...   \n",
       "\n",
       "  Study Results                                         Conditions  \\\n",
       "0            NO                                   Asthma|Pneumonia   \n",
       "1            NO  Respiratory Failure|Respiratory Infection|Aspi...   \n",
       "2            NO  Covid19|Immune Deficiency|Tonsillitis|Tonsil H...   \n",
       "3           YES                                           COVID-19   \n",
       "4            NO                                            Covid19   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                          BEHAVIORAL: medical clown   \n",
       "1  DRUG: Neuromuscular Blocking Agents|DRUG: Anes...   \n",
       "2              DIAGNOSTIC_TEST: Physical examination   \n",
       "3                           DRUG: Hydroxychloroquine   \n",
       "4                    DRUG: Niclosamide|DRUG: Placebo   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  length of experium (seconds), length of experi...  ...   \n",
       "1  Number of participants who either had postoper...  ...   \n",
       "2  The primary outcome of our study was the evalu...  ...   \n",
       "3  Number of Participants Infected With COVID-19 ...  ...   \n",
       "4  SAEs, Serious adverse event (SAE) coded by Sys...  ...   \n",
       "\n",
       "                                        Study Design      Other IDs  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...        0026-15   \n",
       "1  Allocation: RANDOMIZED|Intervention Model: PAR...    2019P000260   \n",
       "2          Observational Model: |Time Perspective: p       2020/480   \n",
       "3  Allocation: NON_RANDOMIZED|Intervention Model:...        020-132   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR...  AZ-NICL-COV-1   \n",
       "\n",
       "   Start Date Primary Completion Date Completion Date First Posted  \\\n",
       "0     2016-03                 2016-10         2017-10   2016-03-15   \n",
       "1  2019-08-07              2022-12-19      2022-12-19   2019-05-24   \n",
       "2  2020-10-01              2021-02-01      2021-02-01   2020-11-30   \n",
       "3  2020-04-03              2020-06-30      2020-06-30   2020-04-03   \n",
       "4  2021-04-30              2022-06-04         2023-05   2021-04-26   \n",
       "\n",
       "  Results First Posted  Last Update Posted  \\\n",
       "0                  NaN          2016-03-15   \n",
       "1                  NaN          2023-02-02   \n",
       "2                  NaN          2020-11-30   \n",
       "3           2021-08-02          2021-08-20   \n",
       "4                  NaN          2023-04-06   \n",
       "\n",
       "                                           Locations  \\\n",
       "0                                                NaN   \n",
       "1  Massachusetts General Hospital, Boston, Massac...   \n",
       "2  Selcuk University, Konya, Selcuklu, 42100, Turkey   \n",
       "3  Baylor University Medical Center, Dallas, Texa...   \n",
       "4  Central Alabama Research, Birmingham, Alabama,...   \n",
       "\n",
       "                            Study Documents  \n",
       "0                                       NaN  \n",
       "1                                       NaN  \n",
       "2                                       NaN  \n",
       "3  Study Protocol|Statistical Analysis Plan  \n",
       "4                                       NaN  \n",
       "\n",
       "[5 rows x 30 columns]"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# loading the pneumonia dataset\n",
    "pn = pd.read_csv(\"Pneumonia-studies.csv\")\n",
    "pn.head()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "# creating a unique column for each of the columns\n",
    "heart['category'] = \"heart\"\n",
    "pn[\"category\"] = \"pneumonia\"\n",
    "mal[\"category\"] = \"malaria\"\n",
    "hiv[\"category\"] = \"Hiv\"\n",
    "cov[\"category\"] = \"Covid\"\n",
    "can[\"category\"] = \"cancer\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>category</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>PROACT</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>...</td>\n",
       "      <td>2005-01|G050208</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2006-02-14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>...</td>\n",
       "      <td>A4070417|2U54MD007600-31</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-04-30</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2018-02-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03176225</td>\n",
       "      <td>Evaluate Safety and Effectiveness of XenoSure ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03176225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The purpose of this clinical trial is to colle...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Diseases</td>\n",
       "      <td>PROCEDURE: Open heart surgery to address the h...</td>\n",
       "      <td>Leakage rate at 6 month post-procedure measure...</td>\n",
       "      <td>...</td>\n",
       "      <td>P15077-1</td>\n",
       "      <td>2017-08-15</td>\n",
       "      <td>2025-11-15</td>\n",
       "      <td>2026-02-15</td>\n",
       "      <td>2017-06-05</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-03-10</td>\n",
       "      <td>Chinese PLA General Hospital, Beijing, Beijing...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00199225</td>\n",
       "      <td>Evaluation of Possible Effects on the QT/ QTc ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00199225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This phase I trial will evaluate the effects o...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Human Experimentation (Human Volunteers)</td>\n",
       "      <td>DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...</td>\n",
       "      <td>To assess whether administration of a repeated...</td>\n",
       "      <td>...</td>\n",
       "      <td>IC012RUP/1/04</td>\n",
       "      <td>2005-02</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2005-07</td>\n",
       "      <td>2005-09-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2005-12-15</td>\n",
       "      <td>Centre de Investigació de Medicaments-Intitut ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT05724225</td>\n",
       "      <td>\"Atriogenic Tricuspid Selected, Omics Profile,...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05724225</td>\n",
       "      <td>ATOMIC</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The aim of our study is to investigate the mol...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Tricuspid Valve Insufficiency</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Protein expression, Evaluation of the protein ...</td>\n",
       "      <td>...</td>\n",
       "      <td>4424</td>\n",
       "      <td>2021-10-06</td>\n",
       "      <td>2022-11-07</td>\n",
       "      <td>2023-12-29</td>\n",
       "      <td>2023-02-13</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-02-15</td>\n",
       "      <td>Istituto Auxologico Italiano IRCSS Ospedale Sa...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 31 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "2  NCT03176225  Evaluate Safety and Effectiveness of XenoSure ...   \n",
       "3  NCT00199225  Evaluation of Possible Effects on the QT/ QTc ...   \n",
       "4  NCT05724225  \"Atriogenic Tricuspid Selected, Omics Profile,...   \n",
       "\n",
       "                                      Study URL Acronym  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  PROACT   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325     NaN   \n",
       "2  https://clinicaltrials.gov/study/NCT03176225     NaN   \n",
       "3  https://clinicaltrials.gov/study/NCT00199225     NaN   \n",
       "4  https://clinicaltrials.gov/study/NCT05724225  ATOMIC   \n",
       "\n",
       "            Study Status                                      Brief Summary  \\\n",
       "0  ACTIVE_NOT_RECRUITING  Various patient groups with the On-X Valve can...   \n",
       "1  ACTIVE_NOT_RECRUITING  Clopidogrel is a prescription medicine used to...   \n",
       "2             RECRUITING  The purpose of this clinical trial is to colle...   \n",
       "3              COMPLETED  This phase I trial will evaluate the effects o...   \n",
       "4  ACTIVE_NOT_RECRUITING  The aim of our study is to investigate the mol...   \n",
       "\n",
       "  Study Results                                         Conditions  \\\n",
       "0            NO                                Heart Valve Disease   \n",
       "1            NO  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "2            NO                                     Heart Diseases   \n",
       "3            NO           Human Experimentation (Human Volunteers)   \n",
       "4            NO                      Tricuspid Valve Insufficiency   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "2  PROCEDURE: Open heart surgery to address the h...   \n",
       "3  DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...   \n",
       "4                                                NaN   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...  ...   \n",
       "1  Major adverse cardiovascular events (MACE) red...  ...   \n",
       "2  Leakage rate at 6 month post-procedure measure...  ...   \n",
       "3  To assess whether administration of a repeated...  ...   \n",
       "4  Protein expression, Evaluation of the protein ...  ...   \n",
       "\n",
       "                  Other IDs  Start Date Primary Completion Date  \\\n",
       "0           2005-01|G050208  2006-06-06              2022-12-31   \n",
       "1  A4070417|2U54MD007600-31  2020-09-01              2023-04-30   \n",
       "2                  P15077-1  2017-08-15              2025-11-15   \n",
       "3             IC012RUP/1/04     2005-02                     NaN   \n",
       "4                      4424  2021-10-06              2022-11-07   \n",
       "\n",
       "  Completion Date First Posted Results First Posted Last Update Posted  \\\n",
       "0      2022-12-31   2006-02-14                  NaN         2022-09-14   \n",
       "1      2023-12-30   2018-02-01                  NaN         2023-05-30   \n",
       "2      2026-02-15   2017-06-05                  NaN         2023-03-10   \n",
       "3         2005-07   2005-09-20                  NaN         2005-12-15   \n",
       "4      2023-12-29   2023-02-13                  NaN         2023-02-15   \n",
       "\n",
       "                                           Locations Study Documents category  \n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...             NaN    heart  \n",
       "1  University Hospital at Carolina, Carolina, 009...             NaN    heart  \n",
       "2  Chinese PLA General Hospital, Beijing, Beijing...             NaN    heart  \n",
       "3  Centre de Investigació de Medicaments-Intitut ...             NaN    heart  \n",
       "4  Istituto Auxologico Italiano IRCSS Ospedale Sa...             NaN    heart  \n",
       "\n",
       "[5 rows x 31 columns]"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "heart.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>category</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>PROACT</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>...</td>\n",
       "      <td>2005-01|G050208</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2006-02-14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>...</td>\n",
       "      <td>A4070417|2U54MD007600-31</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-04-30</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2018-02-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03176225</td>\n",
       "      <td>Evaluate Safety and Effectiveness of XenoSure ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03176225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>The purpose of this clinical trial is to colle...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Diseases</td>\n",
       "      <td>PROCEDURE: Open heart surgery to address the h...</td>\n",
       "      <td>Leakage rate at 6 month post-procedure measure...</td>\n",
       "      <td>...</td>\n",
       "      <td>P15077-1</td>\n",
       "      <td>2017-08-15</td>\n",
       "      <td>2025-11-15</td>\n",
       "      <td>2026-02-15</td>\n",
       "      <td>2017-06-05</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-03-10</td>\n",
       "      <td>Chinese PLA General Hospital, Beijing, Beijing...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00199225</td>\n",
       "      <td>Evaluation of Possible Effects on the QT/ QTc ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00199225</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This phase I trial will evaluate the effects o...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Human Experimentation (Human Volunteers)</td>\n",
       "      <td>DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...</td>\n",
       "      <td>To assess whether administration of a repeated...</td>\n",
       "      <td>...</td>\n",
       "      <td>IC012RUP/1/04</td>\n",
       "      <td>2005-02</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2005-07</td>\n",
       "      <td>2005-09-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2005-12-15</td>\n",
       "      <td>Centre de Investigació de Medicaments-Intitut ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT05724225</td>\n",
       "      <td>\"Atriogenic Tricuspid Selected, Omics Profile,...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT05724225</td>\n",
       "      <td>ATOMIC</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>The aim of our study is to investigate the mol...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Tricuspid Valve Insufficiency</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Protein expression, Evaluation of the protein ...</td>\n",
       "      <td>...</td>\n",
       "      <td>4424</td>\n",
       "      <td>2021-10-06</td>\n",
       "      <td>2022-11-07</td>\n",
       "      <td>2023-12-29</td>\n",
       "      <td>2023-02-13</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2023-02-15</td>\n",
       "      <td>Istituto Auxologico Italiano IRCSS Ospedale Sa...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 31 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "2  NCT03176225  Evaluate Safety and Effectiveness of XenoSure ...   \n",
       "3  NCT00199225  Evaluation of Possible Effects on the QT/ QTc ...   \n",
       "4  NCT05724225  \"Atriogenic Tricuspid Selected, Omics Profile,...   \n",
       "\n",
       "                                      Study URL Acronym  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  PROACT   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325     NaN   \n",
       "2  https://clinicaltrials.gov/study/NCT03176225     NaN   \n",
       "3  https://clinicaltrials.gov/study/NCT00199225     NaN   \n",
       "4  https://clinicaltrials.gov/study/NCT05724225  ATOMIC   \n",
       "\n",
       "            Study Status                                      Brief Summary  \\\n",
       "0  ACTIVE_NOT_RECRUITING  Various patient groups with the On-X Valve can...   \n",
       "1  ACTIVE_NOT_RECRUITING  Clopidogrel is a prescription medicine used to...   \n",
       "2             RECRUITING  The purpose of this clinical trial is to colle...   \n",
       "3              COMPLETED  This phase I trial will evaluate the effects o...   \n",
       "4  ACTIVE_NOT_RECRUITING  The aim of our study is to investigate the mol...   \n",
       "\n",
       "  Study Results                                         Conditions  \\\n",
       "0            NO                                Heart Valve Disease   \n",
       "1            NO  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "2            NO                                     Heart Diseases   \n",
       "3            NO           Human Experimentation (Human Volunteers)   \n",
       "4            NO                      Tricuspid Valve Insufficiency   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "2  PROCEDURE: Open heart surgery to address the h...   \n",
       "3  DRUG: Rupatadine|DRUG: moxifloxacin|PROCEDURE:...   \n",
       "4                                                NaN   \n",
       "\n",
       "                            Primary Outcome Measures  ...  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...  ...   \n",
       "1  Major adverse cardiovascular events (MACE) red...  ...   \n",
       "2  Leakage rate at 6 month post-procedure measure...  ...   \n",
       "3  To assess whether administration of a repeated...  ...   \n",
       "4  Protein expression, Evaluation of the protein ...  ...   \n",
       "\n",
       "                  Other IDs  Start Date Primary Completion Date  \\\n",
       "0           2005-01|G050208  2006-06-06              2022-12-31   \n",
       "1  A4070417|2U54MD007600-31  2020-09-01              2023-04-30   \n",
       "2                  P15077-1  2017-08-15              2025-11-15   \n",
       "3             IC012RUP/1/04     2005-02                     NaN   \n",
       "4                      4424  2021-10-06              2022-11-07   \n",
       "\n",
       "  Completion Date First Posted Results First Posted Last Update Posted  \\\n",
       "0      2022-12-31   2006-02-14                  NaN         2022-09-14   \n",
       "1      2023-12-30   2018-02-01                  NaN         2023-05-30   \n",
       "2      2026-02-15   2017-06-05                  NaN         2023-03-10   \n",
       "3         2005-07   2005-09-20                  NaN         2005-12-15   \n",
       "4      2023-12-29   2023-02-13                  NaN         2023-02-15   \n",
       "\n",
       "                                           Locations Study Documents category  \n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...             NaN    heart  \n",
       "1  University Hospital at Carolina, Carolina, 009...             NaN    heart  \n",
       "2  Chinese PLA General Hospital, Beijing, Beijing...             NaN    heart  \n",
       "3  Centre de Investigació de Medicaments-Intitut ...             NaN    heart  \n",
       "4  Istituto Auxologico Italiano IRCSS Ospedale Sa...             NaN    heart  \n",
       "\n",
       "[5 rows x 31 columns]"
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# merging the whole datasets into one df\n",
    "dfs = [heart,pn,can,hiv,cov,mal]\n",
    "df = pd.concat(dfs, ignore_index=True, sort=False)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [],
   "source": [
    "# This is a function that enables us to  understand our data more better\n",
    "def understanding(df):\n",
    "    \"\"\"This is a function that enables us to understand the data \"\"\"\n",
    "    # data shape\n",
    "    print(f\"Our data consists of {df.shape[1]} columns and {df.shape[0]} rows\")\n",
    "\n",
    "    # understanding the data types\n",
    "    data_types = df.dtypes\n",
    "    print(\"Data Types:\")\n",
    "    print(data_types)\n",
    "\n",
    "    \n",
    "\n",
    "# checking the  aspects of data quality\n",
    "def quality (df):\n",
    "    \"\"\"This is a function that checks for the aspects of data quality\"\"\"\n",
    "    #checking for the missing values\n",
    "    missing = (df.isna().sum()/len(df))*100\n",
    "    missing = missing.sort_values(ascending=False)\n",
    "    print(\"Percentage of missing values:\")\n",
    "    print(missing)\n",
    "\n",
    "    # checking for duplicate values\n",
    "    dups = df.duplicated().sum()\n",
    "    print(\"duplicates:\")\n",
    "    print(dups)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Our data consists of 31 columns and 161863 rows\n",
      "Data Types:\n",
      "NCT Number                     object\n",
      "Study Title                    object\n",
      "Study URL                      object\n",
      "Acronym                        object\n",
      "Study Status                   object\n",
      "Brief Summary                  object\n",
      "Study Results                  object\n",
      "Conditions                     object\n",
      "Interventions                  object\n",
      "Primary Outcome Measures       object\n",
      "Secondary Outcome Measures     object\n",
      "Other Outcome Measures         object\n",
      "Sponsor                        object\n",
      "Collaborators                  object\n",
      "Sex                            object\n",
      "Age                            object\n",
      "Phases                         object\n",
      "Enrollment                    float64\n",
      "Funder Type                    object\n",
      "Study Type                     object\n",
      "Study Design                   object\n",
      "Other IDs                      object\n",
      "Start Date                     object\n",
      "Primary Completion Date        object\n",
      "Completion Date                object\n",
      "First Posted                   object\n",
      "Results First Posted           object\n",
      "Last Update Posted             object\n",
      "Locations                      object\n",
      "Study Documents                object\n",
      "category                       object\n",
      "dtype: object\n"
     ]
    }
   ],
   "source": [
    "# calling the function to understand the data\n",
    "understanding(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Enrollment</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>1.583940e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>9.374003e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>7.689174e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>0.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>3.000000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>7.600000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>2.340000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>1.888141e+08</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         Enrollment\n",
       "count  1.583940e+05\n",
       "mean   9.374003e+03\n",
       "std    7.689174e+05\n",
       "min    0.000000e+00\n",
       "25%    3.000000e+01\n",
       "50%    7.600000e+01\n",
       "75%    2.340000e+02\n",
       "max    1.888141e+08"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# understanding the summary statitics\n",
    "df.describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Percentage of missing values:\n",
      "Study Documents               93.469786\n",
      "Other Outcome Measures        91.902411\n",
      "Results First Posted          87.759401\n",
      "Acronym                       70.016619\n",
      "Collaborators                 62.425014\n",
      "Phases                        49.716118\n",
      "Secondary Outcome Measures    26.064017\n",
      "Interventions                 10.659014\n",
      "Locations                      8.792003\n",
      "Primary Completion Date        5.149416\n",
      "Primary Outcome Measures       5.057981\n",
      "Completion Date                4.524814\n",
      "Enrollment                     2.143170\n",
      "Start Date                     1.455552\n",
      "Study Design                   0.308285\n",
      "Sex                            0.101938\n",
      "Other IDs                      0.012974\n",
      "Conditions                     0.003707\n",
      "First Posted                   0.000000\n",
      "Last Update Posted             0.000000\n",
      "NCT Number                     0.000000\n",
      "Age                            0.000000\n",
      "Study Type                     0.000000\n",
      "Funder Type                    0.000000\n",
      "Study Title                    0.000000\n",
      "Sponsor                        0.000000\n",
      "Study Results                  0.000000\n",
      "Brief Summary                  0.000000\n",
      "Study Status                   0.000000\n",
      "Study URL                      0.000000\n",
      "category                       0.000000\n",
      "dtype: float64\n",
      "duplicates:\n",
      "0\n"
     ]
    }
   ],
   "source": [
    "#  checking the data quality\n",
    "quality(df)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Data Preparation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [],
   "source": [
    "# columns with more than 50% that will be dropped\n",
    "cols = [\"Study Documents\",\"Other Outcome Measures\",\"Results First Posted\",\"Acronym\",\"Collaborators\",\"Phases\"]\n",
    "\n",
    "\n",
    "# dropping columns that have missing values of more than 50%\n",
    "df.drop(cols,axis=1,inplace=True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Percentage of missing values:\n",
      "Secondary Outcome Measures    26.064017\n",
      "Interventions                 10.659014\n",
      "Locations                      8.792003\n",
      "Primary Completion Date        5.149416\n",
      "Primary Outcome Measures       5.057981\n",
      "Completion Date                4.524814\n",
      "Enrollment                     2.143170\n",
      "Start Date                     1.455552\n",
      "Study Design                   0.308285\n",
      "Sex                            0.101938\n",
      "Other IDs                      0.012974\n",
      "Conditions                     0.003707\n",
      "NCT Number                     0.000000\n",
      "Last Update Posted             0.000000\n",
      "First Posted                   0.000000\n",
      "Age                            0.000000\n",
      "Study Type                     0.000000\n",
      "Funder Type                    0.000000\n",
      "Study Title                    0.000000\n",
      "Sponsor                        0.000000\n",
      "Study Results                  0.000000\n",
      "Brief Summary                  0.000000\n",
      "Study Status                   0.000000\n",
      "Study URL                      0.000000\n",
      "category                       0.000000\n",
      "dtype: float64\n",
      "duplicates:\n",
      "0\n"
     ]
    }
   ],
   "source": [
    "quality(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "# dropping rows that contain missing values\n",
    "df.dropna(axis=0,inplace = True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Percentage of missing values:\n",
      "NCT Number                    0.0\n",
      "Enrollment                    0.0\n",
      "Locations                     0.0\n",
      "Last Update Posted            0.0\n",
      "First Posted                  0.0\n",
      "Completion Date               0.0\n",
      "Primary Completion Date       0.0\n",
      "Start Date                    0.0\n",
      "Other IDs                     0.0\n",
      "Study Design                  0.0\n",
      "Study Type                    0.0\n",
      "Funder Type                   0.0\n",
      "Age                           0.0\n",
      "Study Title                   0.0\n",
      "Sex                           0.0\n",
      "Sponsor                       0.0\n",
      "Secondary Outcome Measures    0.0\n",
      "Primary Outcome Measures      0.0\n",
      "Interventions                 0.0\n",
      "Conditions                    0.0\n",
      "Study Results                 0.0\n",
      "Brief Summary                 0.0\n",
      "Study Status                  0.0\n",
      "Study URL                     0.0\n",
      "category                      0.0\n",
      "dtype: float64\n",
      "duplicates:\n",
      "0\n"
     ]
    }
   ],
   "source": [
    "# checking for missing values\n",
    "quality(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00291525</td>\n",
       "      <td>Randomized On-X Anticoagulation Trial</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00291525</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Various patient groups with the On-X Valve can...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Heart Valve Disease</td>\n",
       "      <td>DEVICE: On-X valve using reduced anticoagulati...</td>\n",
       "      <td>Thromboembolism, Rate of thromboembolism evalu...</td>\n",
       "      <td>Valve-Related Events, Rates of other valve-rel...</td>\n",
       "      <td>...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2005-01|G050208</td>\n",
       "      <td>2006-06-06</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>2006-02-14</td>\n",
       "      <td>2022-09-14</td>\n",
       "      <td>Tucson Medical Center, Tucson, Arizona, 85718,...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03419325</td>\n",
       "      <td>A Genomic Approach for Clopidogrel in Caribbea...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03419325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>Clopidogrel is a prescription medicine used to...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Disease (CVD)|Stroke|Acute Coro...</td>\n",
       "      <td>GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...</td>\n",
       "      <td>Major adverse cardiovascular events (MACE) red...</td>\n",
       "      <td>number of patients with treatment-related card...</td>\n",
       "      <td>...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>A4070417|2U54MD007600-31</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2023-04-30</td>\n",
       "      <td>2023-12-30</td>\n",
       "      <td>2018-02-01</td>\n",
       "      <td>2023-05-30</td>\n",
       "      <td>University Hospital at Carolina, Carolina, 009...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03940625</td>\n",
       "      <td>Anthracycline Induced Cardiotoxicity - Early D...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03940625</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Anthracyclines (e.g. Doxorubicin) are an impor...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Breast Cancer|Myocardial Damage|Cardiotoxicity</td>\n",
       "      <td>DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...</td>\n",
       "      <td>reduction of the left ventricular ejection fra...</td>\n",
       "      <td>reduction of the left ventricular global longi...</td>\n",
       "      <td>...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>15-002</td>\n",
       "      <td>2015-06-03</td>\n",
       "      <td>2022-04-30</td>\n",
       "      <td>2022-04-30</td>\n",
       "      <td>2019-05-07</td>\n",
       "      <td>2022-05-25</td>\n",
       "      <td>Division of Cardiology, Pulmonary Disease and ...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT04032925</td>\n",
       "      <td>The Pressure-controlled Intermittent Coronary ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04032925</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The PICSO ViPER study is a prospective single ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Myocardial Infarction</td>\n",
       "      <td>DEVICE: PICSO</td>\n",
       "      <td>End-systolic pressure volume relationship (ESP...</td>\n",
       "      <td>Transcoronary gradient of lactates levels, Car...</td>\n",
       "      <td>...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>14338</td>\n",
       "      <td>2021-08-03</td>\n",
       "      <td>2022-12-29</td>\n",
       "      <td>2022-12-29</td>\n",
       "      <td>2019-07-25</td>\n",
       "      <td>2023-08-21</td>\n",
       "      <td>Oxford Heart Centre, Oxford, OX39DU, United Ki...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT03458325</td>\n",
       "      <td>Furoscix Real-World Evaluation for Decreasing ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03458325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The study is to evaluate the safe admission av...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Heart Failure</td>\n",
       "      <td>COMBINATION_PRODUCT: Furoscix Infusor</td>\n",
       "      <td>Healthcare Utilization Costs, The difference i...</td>\n",
       "      <td>Heart-Failure Related Hospital Admissions, The...</td>\n",
       "      <td>...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>scP-01-005</td>\n",
       "      <td>2020-11-12</td>\n",
       "      <td>2021-06-24</td>\n",
       "      <td>2021-06-24</td>\n",
       "      <td>2018-03-08</td>\n",
       "      <td>2023-02-24</td>\n",
       "      <td>Olive View - UCLA Medical Center, Sylmar, Cali...</td>\n",
       "      <td>heart</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 25 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00291525              Randomized On-X Anticoagulation Trial   \n",
       "1  NCT03419325  A Genomic Approach for Clopidogrel in Caribbea...   \n",
       "5  NCT03940625  Anthracycline Induced Cardiotoxicity - Early D...   \n",
       "7  NCT04032925  The Pressure-controlled Intermittent Coronary ...   \n",
       "8  NCT03458325  Furoscix Real-World Evaluation for Decreasing ...   \n",
       "\n",
       "                                      Study URL           Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT00291525  ACTIVE_NOT_RECRUITING   \n",
       "1  https://clinicaltrials.gov/study/NCT03419325  ACTIVE_NOT_RECRUITING   \n",
       "5  https://clinicaltrials.gov/study/NCT03940625              COMPLETED   \n",
       "7  https://clinicaltrials.gov/study/NCT04032925             TERMINATED   \n",
       "8  https://clinicaltrials.gov/study/NCT03458325              COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  Various patient groups with the On-X Valve can...            NO   \n",
       "1  Clopidogrel is a prescription medicine used to...            NO   \n",
       "5  Anthracyclines (e.g. Doxorubicin) are an impor...            NO   \n",
       "7  The PICSO ViPER study is a prospective single ...            NO   \n",
       "8  The study is to evaluate the safe admission av...           YES   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                                Heart Valve Disease   \n",
       "1  Cardiovascular Disease (CVD)|Stroke|Acute Coro...   \n",
       "5     Breast Cancer|Myocardial Damage|Cardiotoxicity   \n",
       "7                              Myocardial Infarction   \n",
       "8                                      Heart Failure   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DEVICE: On-X valve using reduced anticoagulati...   \n",
       "1  GENETIC: CYP2C19 test|DIAGNOSTIC_TEST: P2RY12 ...   \n",
       "5  DIAGNOSTIC_TEST: Cardiac MRI and echocardiogra...   \n",
       "7                                      DEVICE: PICSO   \n",
       "8              COMBINATION_PRODUCT: Furoscix Infusor   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Thromboembolism, Rate of thromboembolism evalu...   \n",
       "1  Major adverse cardiovascular events (MACE) red...   \n",
       "5  reduction of the left ventricular ejection fra...   \n",
       "7  End-systolic pressure volume relationship (ESP...   \n",
       "8  Healthcare Utilization Costs, The difference i...   \n",
       "\n",
       "                          Secondary Outcome Measures  ...      Study Type  \\\n",
       "0  Valve-Related Events, Rates of other valve-rel...  ...  INTERVENTIONAL   \n",
       "1  number of patients with treatment-related card...  ...  INTERVENTIONAL   \n",
       "5  reduction of the left ventricular global longi...  ...  INTERVENTIONAL   \n",
       "7  Transcoronary gradient of lactates levels, Car...  ...  INTERVENTIONAL   \n",
       "8  Heart-Failure Related Hospital Admissions, The...  ...  INTERVENTIONAL   \n",
       "\n",
       "                                        Study Design  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "5  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "7  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "8  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "\n",
       "                  Other IDs  Start Date Primary Completion Date  \\\n",
       "0           2005-01|G050208  2006-06-06              2022-12-31   \n",
       "1  A4070417|2U54MD007600-31  2020-09-01              2023-04-30   \n",
       "5                    15-002  2015-06-03              2022-04-30   \n",
       "7                     14338  2021-08-03              2022-12-29   \n",
       "8                scP-01-005  2020-11-12              2021-06-24   \n",
       "\n",
       "  Completion Date First Posted Last Update Posted  \\\n",
       "0      2022-12-31   2006-02-14         2022-09-14   \n",
       "1      2023-12-30   2018-02-01         2023-05-30   \n",
       "5      2022-04-30   2019-05-07         2022-05-25   \n",
       "7      2022-12-29   2019-07-25         2023-08-21   \n",
       "8      2021-06-24   2018-03-08         2023-02-24   \n",
       "\n",
       "                                           Locations category  \n",
       "0  Tucson Medical Center, Tucson, Arizona, 85718,...    heart  \n",
       "1  University Hospital at Carolina, Carolina, 009...    heart  \n",
       "5  Division of Cardiology, Pulmonary Disease and ...    heart  \n",
       "7  Oxford Heart Centre, Oxford, OX39DU, United Ki...    heart  \n",
       "8  Olive View - UCLA Medical Center, Sylmar, Cali...    heart  \n",
       "\n",
       "[5 rows x 25 columns]"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [],
   "source": [
    "# dropping columns that are unnecessary columns\n",
    "drop_list = [\"Other IDs\",\"Primay Completion Date\",\"First Posted\"]\n",
    "df = df.drop(drop_list,axis=1)\n",
    "df "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "      <th>country</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NCT03289325</td>\n",
       "      <td>Dexmedetomidine and Long-term Outcomes in Elde...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03289325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>A retrospective study showed that intraoperati...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiac Surgery|Dexmedetomidine|Long-term Outc...</td>\n",
       "      <td>DRUG: dexmedetomidine hydrochloride for inject...</td>\n",
       "      <td>Overall survival after surgery, Overall surviv...</td>\n",
       "      <td>Major adverse cardiovascular events-free survi...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2016-1188</td>\n",
       "      <td>2016-12-01</td>\n",
       "      <td>2022-04</td>\n",
       "      <td>2022-05</td>\n",
       "      <td>2017-09-20</td>\n",
       "      <td>2022-03-09</td>\n",
       "      <td>Peking University First Hospital, Beijing, Bei...</td>\n",
       "      <td>heart</td>\n",
       "      <td>China</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>NCT04907825</td>\n",
       "      <td>A Trial of Pharmacist Management of Oral Antic...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04907825</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This is a prospective, open-label, cluster-ran...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Atrial Fibrillation|Stroke</td>\n",
       "      <td>DRUG: Oral anticoagulant</td>\n",
       "      <td>Optimal OAC Therapy, To determine the differen...</td>\n",
       "      <td>'Actionable' AF Prevalence, To determine the p...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>00000850</td>\n",
       "      <td>2022-01-01</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>2021-06-01</td>\n",
       "      <td>2023-03-24</td>\n",
       "      <td>Cedars-Sinai Medical Center, Los Angeles, Cali...</td>\n",
       "      <td>heart</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>NCT04966325</td>\n",
       "      <td>Thorough QT (TQT) Study to Evaluate the Effect...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04966325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is a Phase 1, single-center, randomized, ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hyperuricemia|Gout|Qt Interval, Variation in</td>\n",
       "      <td>DRUG: LC350189 200mg|DRUG: Placebo|DRUG: Moxif...</td>\n",
       "      <td>The placebo-corrected change from baseline in ...</td>\n",
       "      <td>The placebo-corrected change from baseline in ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>LG-GDCL008</td>\n",
       "      <td>2021-09-23</td>\n",
       "      <td>2021-12-07</td>\n",
       "      <td>2021-12-07</td>\n",
       "      <td>2021-07-19</td>\n",
       "      <td>2022-01-06</td>\n",
       "      <td>PPD, Austin, Texas, 78744, United States</td>\n",
       "      <td>heart</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>NCT02714725</td>\n",
       "      <td>Effect Of Dexmedetomidine On Sublingual Microc...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02714725</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>This study is designed to explore the possible...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Sublingual Microcirculation</td>\n",
       "      <td>DRUG: Dexmedetomidine|DRUG: Placebo for Dexmed...</td>\n",
       "      <td>Change in Microvascular flow index, Microcircu...</td>\n",
       "      <td>Change in Total vascular density, the number o...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>N-54-2015</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2018-05</td>\n",
       "      <td>2018-08</td>\n",
       "      <td>2016-03-21</td>\n",
       "      <td>2018-01-24</td>\n",
       "      <td>Kasr Al-Ainy hospitals , Faculty of medicine ,...</td>\n",
       "      <td>heart</td>\n",
       "      <td>Egypt</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>NCT01683825</td>\n",
       "      <td>Imaging Cardiac Amyloidosis: A Pilot Study Usi...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01683825</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The primary aim of this pilot study is to dete...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Cardiac Amyloidosis</td>\n",
       "      <td>DRUG: F-18 florbetapir PET</td>\n",
       "      <td>Mean Left Ventricular Myocardial F-18 Florbeta...</td>\n",
       "      <td>Percent Change in Global Left Ventricular F-18...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2012P001322</td>\n",
       "      <td>2013-03-23</td>\n",
       "      <td>2018-01-03</td>\n",
       "      <td>2018-10-04</td>\n",
       "      <td>2012-09-12</td>\n",
       "      <td>2022-04-13</td>\n",
       "      <td>Brigham and Women's Hospital, Boston, Massachu...</td>\n",
       "      <td>heart</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161854</th>\n",
       "      <td>NCT02168569</td>\n",
       "      <td>In Vivo Efficacy of Artemether-lumefantrine an...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02168569</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is a classical in vivo clinical trial, fo...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>DRUG: Coartem™ (Artemether-lumefantrine combin...</td>\n",
       "      <td>To measure the Day 28, PCR corrected cure rate...</td>\n",
       "      <td>to evaluate the incidence of adverse events, T...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>134/CNBS/11</td>\n",
       "      <td>2011-06</td>\n",
       "      <td>2012-01</td>\n",
       "      <td>2013-01</td>\n",
       "      <td>2014-06-20</td>\n",
       "      <td>2014-06-20</td>\n",
       "      <td>Hospital Rural de Montepuez, Montepuez, Cabo D...</td>\n",
       "      <td>malaria</td>\n",
       "      <td>Mozambique</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161855</th>\n",
       "      <td>NCT04158713</td>\n",
       "      <td>Improving PRegnancy Outcomes With PReVEntive T...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04158713</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>2.3.3 Short technical protocol summary Backgro...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pregnancy; HIV; Malaria</td>\n",
       "      <td>DRUG: Intermittent Preventive Therapy with Dih...</td>\n",
       "      <td>Cumulative incidence of malaria infection, The...</td>\n",
       "      <td>Efficacy of the intervention on the following ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>17-005</td>\n",
       "      <td>2019-11-11</td>\n",
       "      <td>2022-04-15</td>\n",
       "      <td>2022-08-30</td>\n",
       "      <td>2019-11-12</td>\n",
       "      <td>2023-08-22</td>\n",
       "      <td>Kenya Medical Research Institute, Kisumu, 4010...</td>\n",
       "      <td>malaria</td>\n",
       "      <td>Kenya</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161857</th>\n",
       "      <td>NCT04778813</td>\n",
       "      <td>Evaluation of Three Artemisinin-based Combinat...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04778813</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Bakground In Burkina Faso, since the adoption ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria|Burkina Faso</td>\n",
       "      <td>DRUG: Artemether-lumefantrine</td>\n",
       "      <td>Early treatment failure, * danger signs or sev...</td>\n",
       "      <td>Adverse events frequency and type, Any unwante...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>TET2020_001</td>\n",
       "      <td>2021-06-01</td>\n",
       "      <td>2021-12-31</td>\n",
       "      <td>2022-06-01</td>\n",
       "      <td>2021-03-03</td>\n",
       "      <td>2021-03-03</td>\n",
       "      <td>Centre national de recherche et de formation s...</td>\n",
       "      <td>malaria</td>\n",
       "      <td>Burkina Faso</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161859</th>\n",
       "      <td>NCT01575613</td>\n",
       "      <td>Reducing the Burden of Malaria by Targeting Ho...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01575613</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>In this study, the investigators propose to de...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>DRUG: Artemether-lumefantrine combination|BIOL...</td>\n",
       "      <td>Parasite prevalence in the evaluation zone sur...</td>\n",
       "      <td>Parasite prevalence inside malaria hotspots, P...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>REDHOT_OPP1024438</td>\n",
       "      <td>2012-04</td>\n",
       "      <td>2012-11</td>\n",
       "      <td>2012-11</td>\n",
       "      <td>2012-04-11</td>\n",
       "      <td>2012-11-27</td>\n",
       "      <td>Rachuonyo District, Kenya</td>\n",
       "      <td>malaria</td>\n",
       "      <td>Kenya</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161861</th>\n",
       "      <td>NCT00460369</td>\n",
       "      <td>Treatment of Uncomplicated Malaria in Benin</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00460369</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Malaria is a life-threatening disease especial...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Uncomplicated Malaria</td>\n",
       "      <td>DRUG: sulfadoxine-pyrimethamine|DRUG: artemeth...</td>\n",
       "      <td>efficacy, day 28</td>\n",
       "      <td>effectiveness comparisons (PCR corrected), day...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>Malariallada</td>\n",
       "      <td>2007-04</td>\n",
       "      <td>2007-11</td>\n",
       "      <td>2007-11</td>\n",
       "      <td>2007-04-13</td>\n",
       "      <td>2008-04-14</td>\n",
       "      <td>Centre de santé, Allada, Benin</td>\n",
       "      <td>malaria</td>\n",
       "      <td>Benin</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>51952 rows × 26 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         NCT Number                                        Study Title  \\\n",
       "9       NCT03289325  Dexmedetomidine and Long-term Outcomes in Elde...   \n",
       "10      NCT04907825  A Trial of Pharmacist Management of Oral Antic...   \n",
       "12      NCT04966325  Thorough QT (TQT) Study to Evaluate the Effect...   \n",
       "26      NCT02714725  Effect Of Dexmedetomidine On Sublingual Microc...   \n",
       "44      NCT01683825  Imaging Cardiac Amyloidosis: A Pilot Study Usi...   \n",
       "...             ...                                                ...   \n",
       "161854  NCT02168569  In Vivo Efficacy of Artemether-lumefantrine an...   \n",
       "161855  NCT04158713  Improving PRegnancy Outcomes With PReVEntive T...   \n",
       "161857  NCT04778813  Evaluation of Three Artemisinin-based Combinat...   \n",
       "161859  NCT01575613  Reducing the Burden of Malaria by Targeting Ho...   \n",
       "161861  NCT00460369        Treatment of Uncomplicated Malaria in Benin   \n",
       "\n",
       "                                           Study URL           Study Status  \\\n",
       "9       https://clinicaltrials.gov/study/NCT03289325  ACTIVE_NOT_RECRUITING   \n",
       "10      https://clinicaltrials.gov/study/NCT04907825             RECRUITING   \n",
       "12      https://clinicaltrials.gov/study/NCT04966325              COMPLETED   \n",
       "26      https://clinicaltrials.gov/study/NCT02714725                UNKNOWN   \n",
       "44      https://clinicaltrials.gov/study/NCT01683825             TERMINATED   \n",
       "...                                              ...                    ...   \n",
       "161854  https://clinicaltrials.gov/study/NCT02168569              COMPLETED   \n",
       "161855  https://clinicaltrials.gov/study/NCT04158713              COMPLETED   \n",
       "161857  https://clinicaltrials.gov/study/NCT04778813                UNKNOWN   \n",
       "161859  https://clinicaltrials.gov/study/NCT01575613              COMPLETED   \n",
       "161861  https://clinicaltrials.gov/study/NCT00460369              COMPLETED   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "9       A retrospective study showed that intraoperati...            NO   \n",
       "10      This is a prospective, open-label, cluster-ran...            NO   \n",
       "12      This is a Phase 1, single-center, randomized, ...            NO   \n",
       "26      This study is designed to explore the possible...            NO   \n",
       "44      The primary aim of this pilot study is to dete...           YES   \n",
       "...                                                   ...           ...   \n",
       "161854  This is a classical in vivo clinical trial, fo...            NO   \n",
       "161855  2.3.3 Short technical protocol summary Backgro...            NO   \n",
       "161857  Bakground In Burkina Faso, since the adoption ...            NO   \n",
       "161859  In this study, the investigators propose to de...            NO   \n",
       "161861  Malaria is a life-threatening disease especial...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "9       Cardiac Surgery|Dexmedetomidine|Long-term Outc...   \n",
       "10                             Atrial Fibrillation|Stroke   \n",
       "12           Hyperuricemia|Gout|Qt Interval, Variation in   \n",
       "26                            Sublingual Microcirculation   \n",
       "44                                    Cardiac Amyloidosis   \n",
       "...                                                   ...   \n",
       "161854                                            Malaria   \n",
       "161855                            Pregnancy; HIV; Malaria   \n",
       "161857                               Malaria|Burkina Faso   \n",
       "161859                                            Malaria   \n",
       "161861                              Uncomplicated Malaria   \n",
       "\n",
       "                                            Interventions  \\\n",
       "9       DRUG: dexmedetomidine hydrochloride for inject...   \n",
       "10                               DRUG: Oral anticoagulant   \n",
       "12      DRUG: LC350189 200mg|DRUG: Placebo|DRUG: Moxif...   \n",
       "26      DRUG: Dexmedetomidine|DRUG: Placebo for Dexmed...   \n",
       "44                             DRUG: F-18 florbetapir PET   \n",
       "...                                                   ...   \n",
       "161854  DRUG: Coartem™ (Artemether-lumefantrine combin...   \n",
       "161855  DRUG: Intermittent Preventive Therapy with Dih...   \n",
       "161857                      DRUG: Artemether-lumefantrine   \n",
       "161859  DRUG: Artemether-lumefantrine combination|BIOL...   \n",
       "161861  DRUG: sulfadoxine-pyrimethamine|DRUG: artemeth...   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "9       Overall survival after surgery, Overall surviv...   \n",
       "10      Optimal OAC Therapy, To determine the differen...   \n",
       "12      The placebo-corrected change from baseline in ...   \n",
       "26      Change in Microvascular flow index, Microcircu...   \n",
       "44      Mean Left Ventricular Myocardial F-18 Florbeta...   \n",
       "...                                                   ...   \n",
       "161854  To measure the Day 28, PCR corrected cure rate...   \n",
       "161855  Cumulative incidence of malaria infection, The...   \n",
       "161857  Early treatment failure, * danger signs or sev...   \n",
       "161859  Parasite prevalence in the evaluation zone sur...   \n",
       "161861                                   efficacy, day 28   \n",
       "\n",
       "                               Secondary Outcome Measures  ...  \\\n",
       "9       Major adverse cardiovascular events-free survi...  ...   \n",
       "10      'Actionable' AF Prevalence, To determine the p...  ...   \n",
       "12      The placebo-corrected change from baseline in ...  ...   \n",
       "26      Change in Total vascular density, the number o...  ...   \n",
       "44      Percent Change in Global Left Ventricular F-18...  ...   \n",
       "...                                                   ...  ...   \n",
       "161854  to evaluate the incidence of adverse events, T...  ...   \n",
       "161855  Efficacy of the intervention on the following ...  ...   \n",
       "161857  Adverse events frequency and type, Any unwante...  ...   \n",
       "161859  Parasite prevalence inside malaria hotspots, P...  ...   \n",
       "161861  effectiveness comparisons (PCR corrected), day...  ...   \n",
       "\n",
       "                                             Study Design          Other IDs  \\\n",
       "9       Allocation: RANDOMIZED|Intervention Model: PAR...          2016-1188   \n",
       "10      Allocation: RANDOMIZED|Intervention Model: PAR...           00000850   \n",
       "12      Allocation: RANDOMIZED|Intervention Model: CRO...         LG-GDCL008   \n",
       "26      Allocation: RANDOMIZED|Intervention Model: PAR...          N-54-2015   \n",
       "44      Allocation: NON_RANDOMIZED|Intervention Model:...        2012P001322   \n",
       "...                                                   ...                ...   \n",
       "161854  Allocation: NON_RANDOMIZED|Intervention Model:...        134/CNBS/11   \n",
       "161855  Allocation: RANDOMIZED|Intervention Model: PAR...             17-005   \n",
       "161857  Allocation: RANDOMIZED|Intervention Model: PAR...        TET2020_001   \n",
       "161859  Allocation: RANDOMIZED|Intervention Model: PAR...  REDHOT_OPP1024438   \n",
       "161861  Allocation: RANDOMIZED|Intervention Model: PAR...       Malariallada   \n",
       "\n",
       "        Start Date  Primary Completion Date Completion Date First Posted  \\\n",
       "9       2016-12-01                  2022-04         2022-05   2017-09-20   \n",
       "10      2022-01-01               2024-12-31      2024-12-31   2021-06-01   \n",
       "12      2021-09-23               2021-12-07      2021-12-07   2021-07-19   \n",
       "26         2016-01                  2018-05         2018-08   2016-03-21   \n",
       "44      2013-03-23               2018-01-03      2018-10-04   2012-09-12   \n",
       "...            ...                      ...             ...          ...   \n",
       "161854     2011-06                  2012-01         2013-01   2014-06-20   \n",
       "161855  2019-11-11               2022-04-15      2022-08-30   2019-11-12   \n",
       "161857  2021-06-01               2021-12-31      2022-06-01   2021-03-03   \n",
       "161859     2012-04                  2012-11         2012-11   2012-04-11   \n",
       "161861     2007-04                  2007-11         2007-11   2007-04-13   \n",
       "\n",
       "       Last Update Posted                                          Locations  \\\n",
       "9              2022-03-09  Peking University First Hospital, Beijing, Bei...   \n",
       "10             2023-03-24  Cedars-Sinai Medical Center, Los Angeles, Cali...   \n",
       "12             2022-01-06           PPD, Austin, Texas, 78744, United States   \n",
       "26             2018-01-24  Kasr Al-Ainy hospitals , Faculty of medicine ,...   \n",
       "44             2022-04-13  Brigham and Women's Hospital, Boston, Massachu...   \n",
       "...                   ...                                                ...   \n",
       "161854         2014-06-20  Hospital Rural de Montepuez, Montepuez, Cabo D...   \n",
       "161855         2023-08-22  Kenya Medical Research Institute, Kisumu, 4010...   \n",
       "161857         2021-03-03  Centre national de recherche et de formation s...   \n",
       "161859         2012-11-27                          Rachuonyo District, Kenya   \n",
       "161861         2008-04-14                     Centre de santé, Allada, Benin   \n",
       "\n",
       "       category        country  \n",
       "9         heart          China  \n",
       "10        heart  United States  \n",
       "12        heart  United States  \n",
       "26        heart          Egypt  \n",
       "44        heart  United States  \n",
       "...         ...            ...  \n",
       "161854  malaria     Mozambique  \n",
       "161855  malaria          Kenya  \n",
       "161857  malaria   Burkina Faso  \n",
       "161859  malaria          Kenya  \n",
       "161861  malaria          Benin  \n",
       "\n",
       "[51952 rows x 26 columns]"
      ]
     },
     "execution_count": 104,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# understanding interventions columns\n",
    "def check (name):\n",
    "    \"\"\"Checking for each type of interventipns\"\"\"\n",
    "    int_df = df[df[\"Interventions\"].str.contains(name)==True]\n",
    "    return int_df\n",
    "\n",
    "\n",
    "check(\"COMBINATIO\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "      <th>country</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NCT03289325</td>\n",
       "      <td>Dexmedetomidine and Long-term Outcomes in Elde...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03289325</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>A retrospective study showed that intraoperati...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiac Surgery|Dexmedetomidine|Long-term Outc...</td>\n",
       "      <td>DRUG: dexmedetomidine hydrochloride for inject...</td>\n",
       "      <td>Overall survival after surgery, Overall surviv...</td>\n",
       "      <td>Major adverse cardiovascular events-free survi...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2016-1188</td>\n",
       "      <td>2016-12-01</td>\n",
       "      <td>2022-04</td>\n",
       "      <td>2022-05</td>\n",
       "      <td>2017-09-20</td>\n",
       "      <td>2022-03-09</td>\n",
       "      <td>Peking University First Hospital, Beijing, Bei...</td>\n",
       "      <td>heart</td>\n",
       "      <td>China</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>NCT04907825</td>\n",
       "      <td>A Trial of Pharmacist Management of Oral Antic...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04907825</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>This is a prospective, open-label, cluster-ran...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Atrial Fibrillation|Stroke</td>\n",
       "      <td>DRUG: Oral anticoagulant</td>\n",
       "      <td>Optimal OAC Therapy, To determine the differen...</td>\n",
       "      <td>'Actionable' AF Prevalence, To determine the p...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>00000850</td>\n",
       "      <td>2022-01-01</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>2024-12-31</td>\n",
       "      <td>2021-06-01</td>\n",
       "      <td>2023-03-24</td>\n",
       "      <td>Cedars-Sinai Medical Center, Los Angeles, Cali...</td>\n",
       "      <td>heart</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>NCT04966325</td>\n",
       "      <td>Thorough QT (TQT) Study to Evaluate the Effect...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04966325</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is a Phase 1, single-center, randomized, ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hyperuricemia|Gout|Qt Interval, Variation in</td>\n",
       "      <td>DRUG: LC350189 200mg|DRUG: Placebo|DRUG: Moxif...</td>\n",
       "      <td>The placebo-corrected change from baseline in ...</td>\n",
       "      <td>The placebo-corrected change from baseline in ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>LG-GDCL008</td>\n",
       "      <td>2021-09-23</td>\n",
       "      <td>2021-12-07</td>\n",
       "      <td>2021-12-07</td>\n",
       "      <td>2021-07-19</td>\n",
       "      <td>2022-01-06</td>\n",
       "      <td>PPD, Austin, Texas, 78744, United States</td>\n",
       "      <td>heart</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>NCT02714725</td>\n",
       "      <td>Effect Of Dexmedetomidine On Sublingual Microc...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02714725</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>This study is designed to explore the possible...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Sublingual Microcirculation</td>\n",
       "      <td>DRUG: Dexmedetomidine|DRUG: Placebo for Dexmed...</td>\n",
       "      <td>Change in Microvascular flow index, Microcircu...</td>\n",
       "      <td>Change in Total vascular density, the number o...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>N-54-2015</td>\n",
       "      <td>2016-01</td>\n",
       "      <td>2018-05</td>\n",
       "      <td>2018-08</td>\n",
       "      <td>2016-03-21</td>\n",
       "      <td>2018-01-24</td>\n",
       "      <td>Kasr Al-Ainy hospitals , Faculty of medicine ,...</td>\n",
       "      <td>heart</td>\n",
       "      <td>Egypt</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>NCT01683825</td>\n",
       "      <td>Imaging Cardiac Amyloidosis: A Pilot Study Usi...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01683825</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>The primary aim of this pilot study is to dete...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Cardiac Amyloidosis</td>\n",
       "      <td>DRUG: F-18 florbetapir PET</td>\n",
       "      <td>Mean Left Ventricular Myocardial F-18 Florbeta...</td>\n",
       "      <td>Percent Change in Global Left Ventricular F-18...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2012P001322</td>\n",
       "      <td>2013-03-23</td>\n",
       "      <td>2018-01-03</td>\n",
       "      <td>2018-10-04</td>\n",
       "      <td>2012-09-12</td>\n",
       "      <td>2022-04-13</td>\n",
       "      <td>Brigham and Women's Hospital, Boston, Massachu...</td>\n",
       "      <td>heart</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161854</th>\n",
       "      <td>NCT02168569</td>\n",
       "      <td>In Vivo Efficacy of Artemether-lumefantrine an...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT02168569</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>This is a classical in vivo clinical trial, fo...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>DRUG: Coartem™ (Artemether-lumefantrine combin...</td>\n",
       "      <td>To measure the Day 28, PCR corrected cure rate...</td>\n",
       "      <td>to evaluate the incidence of adverse events, T...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>134/CNBS/11</td>\n",
       "      <td>2011-06</td>\n",
       "      <td>2012-01</td>\n",
       "      <td>2013-01</td>\n",
       "      <td>2014-06-20</td>\n",
       "      <td>2014-06-20</td>\n",
       "      <td>Hospital Rural de Montepuez, Montepuez, Cabo D...</td>\n",
       "      <td>malaria</td>\n",
       "      <td>Mozambique</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161855</th>\n",
       "      <td>NCT04158713</td>\n",
       "      <td>Improving PRegnancy Outcomes With PReVEntive T...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04158713</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>2.3.3 Short technical protocol summary Backgro...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pregnancy; HIV; Malaria</td>\n",
       "      <td>DRUG: Intermittent Preventive Therapy with Dih...</td>\n",
       "      <td>Cumulative incidence of malaria infection, The...</td>\n",
       "      <td>Efficacy of the intervention on the following ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>17-005</td>\n",
       "      <td>2019-11-11</td>\n",
       "      <td>2022-04-15</td>\n",
       "      <td>2022-08-30</td>\n",
       "      <td>2019-11-12</td>\n",
       "      <td>2023-08-22</td>\n",
       "      <td>Kenya Medical Research Institute, Kisumu, 4010...</td>\n",
       "      <td>malaria</td>\n",
       "      <td>Kenya</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161857</th>\n",
       "      <td>NCT04778813</td>\n",
       "      <td>Evaluation of Three Artemisinin-based Combinat...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04778813</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Bakground In Burkina Faso, since the adoption ...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria|Burkina Faso</td>\n",
       "      <td>DRUG: Artemether-lumefantrine</td>\n",
       "      <td>Early treatment failure, * danger signs or sev...</td>\n",
       "      <td>Adverse events frequency and type, Any unwante...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>TET2020_001</td>\n",
       "      <td>2021-06-01</td>\n",
       "      <td>2021-12-31</td>\n",
       "      <td>2022-06-01</td>\n",
       "      <td>2021-03-03</td>\n",
       "      <td>2021-03-03</td>\n",
       "      <td>Centre national de recherche et de formation s...</td>\n",
       "      <td>malaria</td>\n",
       "      <td>Burkina Faso</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161859</th>\n",
       "      <td>NCT01575613</td>\n",
       "      <td>Reducing the Burden of Malaria by Targeting Ho...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01575613</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>In this study, the investigators propose to de...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Malaria</td>\n",
       "      <td>DRUG: Artemether-lumefantrine combination|BIOL...</td>\n",
       "      <td>Parasite prevalence in the evaluation zone sur...</td>\n",
       "      <td>Parasite prevalence inside malaria hotspots, P...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>REDHOT_OPP1024438</td>\n",
       "      <td>2012-04</td>\n",
       "      <td>2012-11</td>\n",
       "      <td>2012-11</td>\n",
       "      <td>2012-04-11</td>\n",
       "      <td>2012-11-27</td>\n",
       "      <td>Rachuonyo District, Kenya</td>\n",
       "      <td>malaria</td>\n",
       "      <td>Kenya</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161861</th>\n",
       "      <td>NCT00460369</td>\n",
       "      <td>Treatment of Uncomplicated Malaria in Benin</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT00460369</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>Malaria is a life-threatening disease especial...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Uncomplicated Malaria</td>\n",
       "      <td>DRUG: sulfadoxine-pyrimethamine|DRUG: artemeth...</td>\n",
       "      <td>efficacy, day 28</td>\n",
       "      <td>effectiveness comparisons (PCR corrected), day...</td>\n",
       "      <td>...</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>Malariallada</td>\n",
       "      <td>2007-04</td>\n",
       "      <td>2007-11</td>\n",
       "      <td>2007-11</td>\n",
       "      <td>2007-04-13</td>\n",
       "      <td>2008-04-14</td>\n",
       "      <td>Centre de santé, Allada, Benin</td>\n",
       "      <td>malaria</td>\n",
       "      <td>Benin</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>51952 rows × 26 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         NCT Number                                        Study Title  \\\n",
       "9       NCT03289325  Dexmedetomidine and Long-term Outcomes in Elde...   \n",
       "10      NCT04907825  A Trial of Pharmacist Management of Oral Antic...   \n",
       "12      NCT04966325  Thorough QT (TQT) Study to Evaluate the Effect...   \n",
       "26      NCT02714725  Effect Of Dexmedetomidine On Sublingual Microc...   \n",
       "44      NCT01683825  Imaging Cardiac Amyloidosis: A Pilot Study Usi...   \n",
       "...             ...                                                ...   \n",
       "161854  NCT02168569  In Vivo Efficacy of Artemether-lumefantrine an...   \n",
       "161855  NCT04158713  Improving PRegnancy Outcomes With PReVEntive T...   \n",
       "161857  NCT04778813  Evaluation of Three Artemisinin-based Combinat...   \n",
       "161859  NCT01575613  Reducing the Burden of Malaria by Targeting Ho...   \n",
       "161861  NCT00460369        Treatment of Uncomplicated Malaria in Benin   \n",
       "\n",
       "                                           Study URL           Study Status  \\\n",
       "9       https://clinicaltrials.gov/study/NCT03289325  ACTIVE_NOT_RECRUITING   \n",
       "10      https://clinicaltrials.gov/study/NCT04907825             RECRUITING   \n",
       "12      https://clinicaltrials.gov/study/NCT04966325              COMPLETED   \n",
       "26      https://clinicaltrials.gov/study/NCT02714725                UNKNOWN   \n",
       "44      https://clinicaltrials.gov/study/NCT01683825             TERMINATED   \n",
       "...                                              ...                    ...   \n",
       "161854  https://clinicaltrials.gov/study/NCT02168569              COMPLETED   \n",
       "161855  https://clinicaltrials.gov/study/NCT04158713              COMPLETED   \n",
       "161857  https://clinicaltrials.gov/study/NCT04778813                UNKNOWN   \n",
       "161859  https://clinicaltrials.gov/study/NCT01575613              COMPLETED   \n",
       "161861  https://clinicaltrials.gov/study/NCT00460369              COMPLETED   \n",
       "\n",
       "                                            Brief Summary Study Results  \\\n",
       "9       A retrospective study showed that intraoperati...            NO   \n",
       "10      This is a prospective, open-label, cluster-ran...            NO   \n",
       "12      This is a Phase 1, single-center, randomized, ...            NO   \n",
       "26      This study is designed to explore the possible...            NO   \n",
       "44      The primary aim of this pilot study is to dete...           YES   \n",
       "...                                                   ...           ...   \n",
       "161854  This is a classical in vivo clinical trial, fo...            NO   \n",
       "161855  2.3.3 Short technical protocol summary Backgro...            NO   \n",
       "161857  Bakground In Burkina Faso, since the adoption ...            NO   \n",
       "161859  In this study, the investigators propose to de...            NO   \n",
       "161861  Malaria is a life-threatening disease especial...            NO   \n",
       "\n",
       "                                               Conditions  \\\n",
       "9       Cardiac Surgery|Dexmedetomidine|Long-term Outc...   \n",
       "10                             Atrial Fibrillation|Stroke   \n",
       "12           Hyperuricemia|Gout|Qt Interval, Variation in   \n",
       "26                            Sublingual Microcirculation   \n",
       "44                                    Cardiac Amyloidosis   \n",
       "...                                                   ...   \n",
       "161854                                            Malaria   \n",
       "161855                            Pregnancy; HIV; Malaria   \n",
       "161857                               Malaria|Burkina Faso   \n",
       "161859                                            Malaria   \n",
       "161861                              Uncomplicated Malaria   \n",
       "\n",
       "                                            Interventions  \\\n",
       "9       DRUG: dexmedetomidine hydrochloride for inject...   \n",
       "10                               DRUG: Oral anticoagulant   \n",
       "12      DRUG: LC350189 200mg|DRUG: Placebo|DRUG: Moxif...   \n",
       "26      DRUG: Dexmedetomidine|DRUG: Placebo for Dexmed...   \n",
       "44                             DRUG: F-18 florbetapir PET   \n",
       "...                                                   ...   \n",
       "161854  DRUG: Coartem™ (Artemether-lumefantrine combin...   \n",
       "161855  DRUG: Intermittent Preventive Therapy with Dih...   \n",
       "161857                      DRUG: Artemether-lumefantrine   \n",
       "161859  DRUG: Artemether-lumefantrine combination|BIOL...   \n",
       "161861  DRUG: sulfadoxine-pyrimethamine|DRUG: artemeth...   \n",
       "\n",
       "                                 Primary Outcome Measures  \\\n",
       "9       Overall survival after surgery, Overall surviv...   \n",
       "10      Optimal OAC Therapy, To determine the differen...   \n",
       "12      The placebo-corrected change from baseline in ...   \n",
       "26      Change in Microvascular flow index, Microcircu...   \n",
       "44      Mean Left Ventricular Myocardial F-18 Florbeta...   \n",
       "...                                                   ...   \n",
       "161854  To measure the Day 28, PCR corrected cure rate...   \n",
       "161855  Cumulative incidence of malaria infection, The...   \n",
       "161857  Early treatment failure, * danger signs or sev...   \n",
       "161859  Parasite prevalence in the evaluation zone sur...   \n",
       "161861                                   efficacy, day 28   \n",
       "\n",
       "                               Secondary Outcome Measures  ...  \\\n",
       "9       Major adverse cardiovascular events-free survi...  ...   \n",
       "10      'Actionable' AF Prevalence, To determine the p...  ...   \n",
       "12      The placebo-corrected change from baseline in ...  ...   \n",
       "26      Change in Total vascular density, the number o...  ...   \n",
       "44      Percent Change in Global Left Ventricular F-18...  ...   \n",
       "...                                                   ...  ...   \n",
       "161854  to evaluate the incidence of adverse events, T...  ...   \n",
       "161855  Efficacy of the intervention on the following ...  ...   \n",
       "161857  Adverse events frequency and type, Any unwante...  ...   \n",
       "161859  Parasite prevalence inside malaria hotspots, P...  ...   \n",
       "161861  effectiveness comparisons (PCR corrected), day...  ...   \n",
       "\n",
       "                                             Study Design          Other IDs  \\\n",
       "9       Allocation: RANDOMIZED|Intervention Model: PAR...          2016-1188   \n",
       "10      Allocation: RANDOMIZED|Intervention Model: PAR...           00000850   \n",
       "12      Allocation: RANDOMIZED|Intervention Model: CRO...         LG-GDCL008   \n",
       "26      Allocation: RANDOMIZED|Intervention Model: PAR...          N-54-2015   \n",
       "44      Allocation: NON_RANDOMIZED|Intervention Model:...        2012P001322   \n",
       "...                                                   ...                ...   \n",
       "161854  Allocation: NON_RANDOMIZED|Intervention Model:...        134/CNBS/11   \n",
       "161855  Allocation: RANDOMIZED|Intervention Model: PAR...             17-005   \n",
       "161857  Allocation: RANDOMIZED|Intervention Model: PAR...        TET2020_001   \n",
       "161859  Allocation: RANDOMIZED|Intervention Model: PAR...  REDHOT_OPP1024438   \n",
       "161861  Allocation: RANDOMIZED|Intervention Model: PAR...       Malariallada   \n",
       "\n",
       "        Start Date  Primary Completion Date Completion Date First Posted  \\\n",
       "9       2016-12-01                  2022-04         2022-05   2017-09-20   \n",
       "10      2022-01-01               2024-12-31      2024-12-31   2021-06-01   \n",
       "12      2021-09-23               2021-12-07      2021-12-07   2021-07-19   \n",
       "26         2016-01                  2018-05         2018-08   2016-03-21   \n",
       "44      2013-03-23               2018-01-03      2018-10-04   2012-09-12   \n",
       "...            ...                      ...             ...          ...   \n",
       "161854     2011-06                  2012-01         2013-01   2014-06-20   \n",
       "161855  2019-11-11               2022-04-15      2022-08-30   2019-11-12   \n",
       "161857  2021-06-01               2021-12-31      2022-06-01   2021-03-03   \n",
       "161859     2012-04                  2012-11         2012-11   2012-04-11   \n",
       "161861     2007-04                  2007-11         2007-11   2007-04-13   \n",
       "\n",
       "       Last Update Posted                                          Locations  \\\n",
       "9              2022-03-09  Peking University First Hospital, Beijing, Bei...   \n",
       "10             2023-03-24  Cedars-Sinai Medical Center, Los Angeles, Cali...   \n",
       "12             2022-01-06           PPD, Austin, Texas, 78744, United States   \n",
       "26             2018-01-24  Kasr Al-Ainy hospitals , Faculty of medicine ,...   \n",
       "44             2022-04-13  Brigham and Women's Hospital, Boston, Massachu...   \n",
       "...                   ...                                                ...   \n",
       "161854         2014-06-20  Hospital Rural de Montepuez, Montepuez, Cabo D...   \n",
       "161855         2023-08-22  Kenya Medical Research Institute, Kisumu, 4010...   \n",
       "161857         2021-03-03  Centre national de recherche et de formation s...   \n",
       "161859         2012-11-27                          Rachuonyo District, Kenya   \n",
       "161861         2008-04-14                     Centre de santé, Allada, Benin   \n",
       "\n",
       "       category        country  \n",
       "9         heart          China  \n",
       "10        heart  United States  \n",
       "12        heart  United States  \n",
       "26        heart          Egypt  \n",
       "44        heart  United States  \n",
       "...         ...            ...  \n",
       "161854  malaria     Mozambique  \n",
       "161855  malaria          Kenya  \n",
       "161857  malaria   Burkina Faso  \n",
       "161859  malaria          Kenya  \n",
       "161861  malaria          Benin  \n",
       "\n",
       "[51952 rows x 26 columns]"
      ]
     },
     "execution_count": 100,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pycountry\n",
    "\n",
    "# Function to get country from location text\n",
    "def extract_country(location_text):\n",
    "    for country in pycountry.countries:\n",
    "        if country.name in location_text:\n",
    "            return country.name\n",
    "\n",
    "    if \"Taiwan\" in location_text:\n",
    "        return \"Taiwan\"\n",
    "    \n",
    "    elif \"Czech\" in location_text:\n",
    "        return \"Czech Republic\"\n",
    "    \n",
    "    elif \"Tanzania\" in location_text:\n",
    "        return \"Tanzania\"\n",
    "    \n",
    "    elif \"Vietnam\" in location_text:\n",
    "        return \"Vietnam\"\n",
    "    \n",
    "    elif \"Swaziland\" in location_text:\n",
    "        return \"Swaziland\"\n",
    "    \n",
    "    elif \"Côte D'Ivoire\" in location_text:\n",
    "        return \"Côte D'Ivoire\"\n",
    "    \n",
    "    elif \"Venezuela\" in location_text:\n",
    "        return \"Venezuela\"\n",
    "    \n",
    "    elif \"Bolivia\" in location_text:\n",
    "        return \"Bolivia\"\n",
    "    \n",
    "    elif \"Palestinian\" in location_text:\n",
    "        return \"Palestine\"\n",
    "    \n",
    "    elif \"Macedonia\"  in location_text:\n",
    "        return \"Macedonia\"\n",
    "     # Return \"Unknown\" if no country is found\n",
    "    return \"Kosovo\"\n",
    "\n",
    "# Assuming you have a DataFrame named 'df' with a 'Locations' column\n",
    "df['country'] = df['Locations'].apply(extract_country)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0                 Canada\n",
      "1            Puerto Rico\n",
      "5                Germany\n",
      "7         United Kingdom\n",
      "8                  India\n",
      "               ...      \n",
      "161856             Niger\n",
      "161857      Burkina Faso\n",
      "161859             Kenya\n",
      "161860             India\n",
      "161861             Benin\n",
      "Name: country, Length: 98065, dtype: object\n"
     ]
    }
   ],
   "source": [
    "# checking if the countries have been created\n",
    "print(df[\"country\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [],
   "source": [
    "count = df[\"country\"].value_counts()\n",
    "\n",
    "country = pd.DataFrame(count)\n",
    "\n",
    "pd.set_option(\"display.max_rows\",500)\n",
    "#country.head(160)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>category</th>\n",
       "      <th>country</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>0 rows × 26 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [NCT Number, Study Title, Study URL, Study Status, Brief Summary, Study Results, Conditions, Interventions, Primary Outcome Measures, Secondary Outcome Measures, Sponsor, Sex, Age, Enrollment, Funder Type, Study Type, Study Design, Other IDs, Start Date, Primary Completion Date, Completion Date, First Posted, Last Update Posted, Locations, category, country]\n",
       "Index: []\n",
       "\n",
       "[0 rows x 26 columns]"
      ]
     },
     "execution_count": 99,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.loc[df[\"country\"]==\"Unknown\"]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Data Preparationv"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "dan",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
